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1Executive summary
T he project ‘Learning from Promising Primary Care Practice Models for the USA’, being implemented by the Training and Research Support Centre (TARSC) 
in association with Robert Wood Johnson Foundation 
(RWJF), seeks to identify and describe promising primary 
care practice models and approaches in countries with better 
health outcomes at lower costs than in the United States of 
America (USA) that have relevance to US application. This 
is to inform policy and practitioner dialogue on models and 
measures that could be adapted or adopted in the USA. 
This paper identifies features of primary care (PC) practice 
models within the UK, with a specific, though not exclusive, 
focus on England that show positive health outcomes in 
terms of access, equity, quality and efficiency and that are 
associated with effective use of resources to improve health 
outcomes, especially for those with highest health needs.
We reviewed published and grey literature from 1990 
onwards on PC systems and on specific, promising PC 
system innovations. A total of 112 published and grey 
literature documents/information sources were included. 
Key informant interviews were conducted with ten 
policy, management and professional level informants and 
representatives of civil society organisations. The interviews 
explored the underlying strategies and mechanisms for 
achieving the system-wide results in promising practice 
areas. The informants were identified by experts on the 
review team and during the rapid review of published and 
grey literature.
Essential ingredients. The English PC system must be 
understood within the context of a long-standing, publicly 
and politically popular universal healthcare system, the 
National Health Service (NHS). The NHS was designed 
from the outset to be more equitable, efficient and effective 
than the patchwork of services it replaced (Section 3.1). 
The building blocks of universal entitlement, equitable 
financing, services free at the point of use, comprehensive 
healthcare coverage, equality of geographic access, high 
standards of care for all, selection on the basis of need and 
the encouragement of a non-exploitative ethos underpin 
the policies and specific models that maintain and enhance 
primary care in the NHS.
The NHS has a strong PC base in comparison to other OECD 
countries (Section 3.2). Over 90% of healthcare interactions 
take place in PC, despite a PC budget of under 10% of the 
total NHS budget of approximately £105 billion/$178 billion 
annually. More than 99% of the 52 million people living 
in England are registered with a general practitioner (GP). 
Patient satisfaction with PC is high and satisfaction with the 
NHS in general is high, although it has fallen since 2010. 
Section 3.5 details some impressive outcomes and impacts 
of the English NHS in comparison with other high-income 
countries, in terms of access, efficiency and equity.
Important components of the infrastructure for PC, described 
in this case study, help make it strong. The common GP 
contract, support for common information systems and the 
use of those systems to establish professional norms all help 
it function as a unified system. The information systems and 
patient records also support the oversight of PC services and 
the management of change.
The near universal registration of the population with a 
general practice is another asset, coupled with the fact that 
two-thirds of the population have a GP consultation every 
year, rising to 90% over five years. This provides levels 
of contact, coverage and continuity between PC and the 
general public achieved by few other public services.
Another important aspect is the role of GPs as gatekeepers 
to specialist care and beyond. Gatekeeping is seen as an 
essential, structural component of the system, reducing 
unnecessary and expensive access to specialists and 
containing health problems within the community where 
they can be more appropriately treated. It also helps protect 
patients against over-treatment and excessive exposure to 
radiation during diagnostic tests, for example.
The case study identifies a somewhat intangible aspect 
that nonetheless makes the system work – the status of the 
GPs and respect for their expertise (Section 4.3). Public 
perceptions of GPs have been enhanced by general practice 
being treated as a specialism, requiring the depth of training 
approaching secondary care specialties. Also, continued 
attempts have been made to raise the income levels of GPs 
to that of hospital consultants.
2Relationships between PC providers and the public may 
have been enhanced in recent years through greater patient 
and public involvement (PPI), now operating at all levels of 
the NHS, described in Section 3.3. Voluntary sector support 
networks and organisations can play a key role in helping 
individuals navigate complex health systems, particularly 
during periods of change. Practice health champions have the 
potential to enhance patient access to decision making and 
may assist patients, particularly those from disadvantaged 
backgrounds, in understanding complex health issues and 
health systems. The extent of PPI is not uniform across 
PC, however, and can be tokenistic. The experience of the 
PC system from the patient’s perspective is outlined in 
Section 3.4. 
Promising PC initiatives. A number of PC policy 
initiatives are outlined in the case study that may be of 
particular interest for the US system. The first is the Quality 
and Outcomes Framework (QOF), introduced at a cost of 
more than £1 billion/$1.7 billion per annum, as a ‘payment 
for performance’ scheme to incentivise GPs to make 
improvements in secondary prevention and quality of care 
for chronic conditions (Section 4.1). Active monitoring 
in the QOF has contributed to its impacts on quality and 
outcomes. The case study points to the potential for QOF 
to reduce inequalities by ensuring systematic management 
of chronic conditions, but also the potential to increase 
inequalities by diverting attention from non-incentivised 
areas. Thresholds may act as a ‘quality ceiling’, preventing 
further improvements. This points to the need for careful 
selection and regular management of the indicators and 
related quality thresholds to avoid negative effects, and 
professional buy-in to minimise ‘gaming’ of the system.
The second is the introduction of the National Institute for 
Health and Clinical Excellence (NICE) (Section 4.2). NICE 
has standardised care in many areas across the NHS and 
helped to ensure equitable access to new health technologies. 
It has played a key role in balancing the costs and benefits 
of healthcare technologies (value for money). The strength 
of NICE is the imposition of national-level standards; the 
weakness is the inflexibility of those standards, which may 
undermine a doctor’s discretion to tailor treatment to the 
individual patient. It provides a method and evidence that 
may be used and adapted in other countries.
The third policy initiative is the promotion of the training 
and status of GPs as ‘Expert Generalists’, the term the 
Royal College of General Practitioners uses to characterise 
the specialist nature of the profession (Section 4.3). It adds 
to the acceptability and trust that patients need to have in 
general practice if they are to accept the gatekeeping role 
of their GP.
Finally, a series of experiments over the years to improve 
access to, and delivery of, PC services to disadvantaged 
groups and areas of the country are outlined in Section 4.3. 
Some have proved relatively ineffectual, while others, such 
as the ‘GPs at the Deep End’ initiative in Scotland and the 
PC services adapted to serve the needs of homeless people 
in the North West of England, provide inspiration on how to 
reverse the Inverse Care Law.
A note of warning is sounded about current NHS reforms 
that may undermine many aspects of the unified system that 
is described in this case study.
31. Introduction
T he project ‘Learning from Promising Primary Care Practice Models for the USA’, coordinated by Training and Research Support Centre, seeks 
to identify and describe promising primary care (PC) 
practice models and approaches in countries with better 
health outcomes at lower costs than in the United States of 
America (USA) that have relevance to US application. This 
is to inform policy and practitioner dialogue on models and 
measures that could be adapted or adopted in the USA. This 
paper presents a country case study for the project on UK, 
with a focus on England. As set out in the protocol, it aims 
to identify features of PC practice models within UK, with 
a specific, though not exclusive, focus on England that show 
positive health outcomes in terms of access, equity, quality 
and efficiency and that are associated with effective use of 
resources to achieve improved health outcomes, especially 
for those with highest health need.
Towards this it presents evidence on: (i) the general and 
health system context; (ii) the PC system and service 
delivery models; (iii) social roles and interactions and 
other factors that support improved health and healthcare 
outcomes; and (iv) on how these policies and practices were 
introduced and sustained. This evidence is used to inform 
discussions about whether there may be promising features 
of the PC system in the UK that could hold useful lessons 
for application in the USA. The evidence was gathered and 
is reported within the areas of a conceptual framework for 
the programme (Loewenson and Simpson 2014).
i. Section 1 locates PC in the context of the universal 
healthcare system as a whole.
ii. In Section 2, PC service delivery is explained, 
including the services available in a typical health 
centre from the patient’s perspective, and the way the 
system works from the point of view of the general 
practitioner (GP).
iii. Section 3 presents evidence on particular policy 
initiatives in the UK PC system that could hold lessons 
for application in the USA, including initiatives to:
 ᵒ Incentivise quality improvement and preventive 
activities in PC (Quality and Outcomes 
Framework (QOF));
 ᵒ Improve standards and effectiveness of care for 
patients (the National Institute for Health and 
Care Excellence (NICE) innovation);
 ᵒ Promote the specialist training and status of 
Expert Generalists in PC;
 ᵒ Improve access and quality of PC in disadvantaged 
areas; and
 ᵒ Promote public and patient involvement in 
decisions about PC and in the NHS as a whole.
42. Methods
D ocument review: A rapid review of published and grey literature identified key government/policy documents, statements and reviews; relevant 
operational documents from health authorities and systems; 
and reports and evaluations of specific reforms, innovations 
or practices. To account for long-term changes in PC 
services, influenced for example by changing political, 
economic and demographic landscapes, this included 
documents from 1990 onwards and important antecedent 
documents. Published literature on specific, promising PC 
system innovations, for example, the pay-for-performance 
QOF and the establishment of the NICE, were located 
through focused searches of the following electronic 
databases: MEDLINE, EconLit and HMIC. Searches of 
Google Scholar were also carried out to locate publications 
by identified experts. Publications were also identified 
by experts during key informant interviews and through 
manually searching the reference lists of included studies.
Grey literature was identified through searches of 
relevant organisational websites, including government 
departments and National Health Service (NHS) bodies 
(such as NICE) professional standard-setting organisations 
(such as the Royal College of Physicians), patient and 
public involvement bodies (such as INVOLVE), relevant 
research groups/foundations (such as The King’s Fund), 
and international bodies (such as OECD). A search of the 
grey literature database OpenGrey was also conducted. 
The searches focused on policy documents describing the 
component parts of the system and any relevant changes 
to the system, together with assessments of the impact of 
any system changes relating to: mechanisms and measures 
to ensure quality, universalism and equity in PC; cost-
effectiveness; and changes that help achieve high levels of 
public satisfaction with PC and to ensure access to high 
quality PC for disadvantaged populations/areas. A total of 
112 published and grey literature documents/information 
sources were included.
Key informant interviews. Key informant interviews 
were conducted with a mix of policy, management and 
professional informants and representatives of civil society 
organisations to explore the underlying strategies and 
mechanisms for achieving the system-wide results in relation 
to the identified promising practice areas. The informants 
were identified by experts on the review team and during 
the rapid review of published and grey literature. Ten key 
informants were interviewed with specialist knowledge and 
experience of:
• Public involvement and accountability in the way PC 
services are run;
• Equitable resource allocation strategies;
• The operation and impact of NICE and the QOF;
• The Royal College of General Practitioners (RCGP) 
on the system and impact of GP specialist training and 
standards;
• Promising initiatives to ensure access to effective PC 
services for disadvantaged groups and areas; and
• Initiatives in PC to tackle the wider social determinants 
of health.
To ensure full and frank discussion of the strengths and 
limitations of the PC initiatives, the identities of the key 
informants have been anonymised within the results. 
Ethical approval for the study was obtained from the 
University of Liverpool, Institute of Psychology Health 
and Society Research Ethics Committee (8 April 2014). 
Limitations include the small and highly selective sample 
of key informants who could not provide a comprehensive 
perspective on all aspects of the English PC system. On 
the other hand, the purposive sampling directed us to 
informants who had extensive experience of the specific, 
promising initiatives and could provide historical and 
strategic insights.
53. Findings
3.1 The context for the PC system in 
England
T his section outlines key features of the general and health system context for PC in the UK.
General context of a universal healthcare 
system – the NHS
The PC system in England cannot be understood without 
considering the overarching context of the universal 
healthcare system that exists in the country, within which 
PC is embedded. Since its establishment in 1948, there has 
been overwhelming public and political support for the 
provision of a NHS, with the full force of legislation and 
statutory regulations behind it. The fundamental design 
of the NHS incorporates key principles to make it more 
equitable, efficient and effective than the patchwork of 
services that preceded it (Whitehead 1994):
Box 1: Key principles of the NHS
i. Universal entitlement: everyone to be included in the scheme as a right, without having to undergo a means test 
or other test of eligibility;
ii. Equitable financing of the system: through progressive general taxation, so that everyone contributes in 
proportion to their income into a general fund, and everyone’s risk is pooled through the same mechanism (i.e. 
an important mechanism for supporting solidarity), thereby protecting all from catastrophic costs if they fall ill;
iii. Free at the point of use: no user charges or co-payments for using the services, so that, in the words of Aneurin 
Bevan (1946), one of the founders of the NHS, “money ought not to be permitted to stand in the way of obtaining 
an efficient service”;
iv. Comprehensive in range: coverage not limited to hospital care, but including the range of prevention and health 
promotion to treatment, rehabilitation and palliative care; primary to tertiary care; and care of mental and 
physical health; chronic and acute conditions;
v. Equality of geographic access: commitment to improve the geographic distribution of services and physical 
access/availability to reach everyone with essential healthcare;
vi. The same high standard of care for all: establishing national standards of quality to ‘level up’ to, independent of 
status and where a person lives;
vii. Selection on the basis of need: in situations of scarcity, people have the right to expect that no one would be 
able to gain access to a service ahead of others in equal need by money or other social influence; and
viii. Encouragement of a non-exploitative ethos: by maintaining high professional and ethical standards, and 
minimising incentives for providers to profit from patients.
Over the sixty or so years since the NHS was introduced, 
commentators have debated the extent to which these 
principles have been (or indeed could be) achieved. It is, 
however, still the case that these principles remain the 
building blocks of the current system, and help hold it 
together in an integrated whole (Whitehead 1988; Smith 
2014). They underpin many policies that have been 
introduced to maintain and improve PC.
6The position of PC within the NHS: 
In international comparisons, the NHS is considered to 
have a strong PC base, one of the strongest of the OECD 
countries (Starfield et al. 2014). The NHS in England serves 
a population of 52 million people and spends about 8.4% of 
gross domestic product. The vast majority of the population 
(more than 99%) are registered with a GP (ONS 2012). 
There is universal registration with a single practice of the 
patient’s choice, and GPs provide all primary medical care 
(Roland et al. 2012). An estimated 90% of all healthcare 
interactions are dealt with at PC level (with only 9% going 
on to outpatient secondary care and only 1% to inpatient 
hospital care). Although PC deals with the bulk of healthcare 
needs in England, in 2011/12 it did so on less than 10% of 
the total NHS budget of £105 billion ($178.5 billion at an 
exchange rate of £1 to $1.70 in June 2014) falling to 8.5% of 
the budget by 2014 (House of Commons Library 2012). One 
reason is that it is more efficient to treat people in PC, where 
it is less expensive than hospital care, and more effective to 
treat disease early, before acute episodes develop. Another 
reason is that GPs occupy a gatekeeping role in the system: 
patients gain access to NHS hospital care, community 
nursing services and prescription medicines only through 
their GP, with the exception of Accident and Emergency 
(A&E) services that have direct access.
In 2011, about 11% of the UK population (about 6.9 million 
people) had private medical insurance in addition to their 
eligibility for the NHS. Two-thirds of the insurance policies 
were funded by employers as an employee benefit, and 
only one third were self-funded (Pollard, 2012). However, 
all people with private medical insurance are also covered 
by the NHS, and nearly all use NHS services to the full 
extent. They use NHS PC, emergency care and non-
elective secondary and tertiary care. Use of private medical 
insurance is overwhelming restricted to elective hospital 
care, such as to shorten waiting times for elective surgery.
The NHS from the public’s perspective: 
All residents in the country finance the NHS through their 
taxes. On average, the budget allocated to the NHS from 
general taxation equated in 2011 to an average contribution 
of about £2,000 ($3,400) per person per year, although with 
contributions income related (Davis et al. 2014). Given this 
prepayment, services are free at point of care, for primary 
and community care, hospital inpatient and outpatient 
care and emergency treatment. Charges for prescription 
medicines are capped, but exceptions mean that more than 
90% of prescriptions are free.
Regular surveys show high patient satisfaction and 
reasonably high staff satisfaction, discussed further in 
Section 3.5. Overall trust in the NHS UK fell from 70% in 
2010, following a long period of investment, to 61% in 2012 
after reforms introduced by the new government, (NatCen 
2013).
Current reforms: 
Currently, the public health and PC systems have been 
the subject of radical reforms introduced by the incoming 
coalition government in 2010, in the White Paper 
‘Liberating the NHS’ (DoH 2010). As part of these reforms, 
which came into effect fully in April 2013, Primary Care 
Trusts (PCTs), discussed in Section 3.2 have been dissolved 
and their functions transferred to newly formed Clinical 
Commissioning Groups (CCGs) for the commissioning 
of community and secondary care services; to NHS 
England for the commissioning of PC services; to local 
government organisations (such as city councils) for the 
health improvement aspects of the public health services 
(so these public health services have moved out of the NHS 
altogether). A new body, Public Health England, an executive 
agency of the national Department of Health, not part of the 
NHS, is responsible for overseeing both health improvement 
and health protection aspects of public health (including 
absorbing the Health Protection Agency). Following 
the abolition of (regional) Strategic Health Authorities 
(SHAs) which oversaw the work of the former PCTs, NHS 
Commissioning Boards (NHS CBs) operating at national, 
regional and local levels (the latter named NHS CB Local 
Area Teams [NHS CB LATs]) were established to provide 
leadership to the NHS, hold CCGs to account for delivering 
their statutory responsibilities, and to commission services 
such as primary care, specialised services, prison health 
and military health (BMA 2012).
It is too early to judge what the effect of these reforms will 
be, but grave concerns have been expressed concerning 
these and other aspects of the NHS reforms brought in under 
the Health and Social Care Act (Whitehead et al. 2010; 
Walshe 2010, 2012; Hunter 2012; McKee 2012; Pollock 
and Price 2011; Pollock 2012; Pollock et al. 2012a, 2012b 
2012c, 2012d) These and other strong critiques warn that the 
reforms were introduced without debate or public mandate, 
to address a non-existent problem and would undermine 
or dismantle many fundamental building blocks described 
throughout this case study − the structures that make the 
NHS efficient, effective and equitable. This eventuality is 
being fought at all costs (Smith 2014), and will be further 
discussed in the final section.
3.2 PC service delivery
PC services in the NHS are delivered through general 
practices (GPs), community nursing services (including 
district nursing and health visiting, school nursing), 
dentistry and community pharmacy, together with a range 
of professions allied to medicine working in the community 
(as opposed to in hospitals).
Patient registration and records: The system is designed 
for general practice to be the first point of contact for 
PC and for gaining access to the rest of the NHS system 
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All persons All males All females
Population mid-2010 (rounded) 52,234 25,753 26,476
Population registered with a GP* 52,010 25,562 26,449
Percent population registered with a GP** 99.57 99.24 99.89
* Registration figures were adjusted by the ONS to account for double registrations. 
**Percentage calculations based on non-rounded figures. 
Source: ONS 2012
Patients only have to register once, when they join the list 
of a particular GP (as opposed to annually as in some other 
systems), and it is the norm for patients to stay with their 
chosen practice for long periods, typically only changing if 
they move out of the area. Patients living within (a defined) 
catchment area of a practice that is accepting new patients 
complete a form to register formally with the practice. A 
local NHS Commissioning Board (twenty seven of which 
cover the whole country) coordinates registration, arranging 
for the patient’s medical records, from all levels of care, 
to be transferred and kept by their GP practice. All NHS 
IT systems can identify the practice a patient is registered 
to through a NHS identification number or personal 
information (name, address, date of birth).
PC workforce and facilities:  
As Table 2 shows, approximately 36,000 whole-time 
equivalent GPs are working in 8,000 GP practices in 
England. Only 11.8% are solo practices. The majority, more 
than 88% of practices, consist of a group of several GPs 
working in partnership, some of whom may be salaried 
(paid by the practice).
Table 2: Staff working in general practice in England in 2013
Staff type Number – Full- 
time equivalent 
(FTE) 2013
Average number 
of registered 
patients per GP
Number of GP 
practices
Average number 
of FTE GPs per 
GP practice
GPs* 36,294 1,500 8,000 5
Nurses** 14,943
Other practice staff 72,201
*All GPs (providers, salaried/other). A proportion of GPs work part time, so the numbers are given in whole-time equivalents. **All 
nurses employed by general practices. 
Source: HSCIC 2014
The average number of GPs in a practice is five, though 
the range is wide. Group practices work out of health 
centres or primary medical centres in which a wide range 
of community health services are provided. GPs directly 
employ general practice nurses and specialist nurses for 
specific disease-based clinics, nursing assistants, health 
promotion workers and administrative staff. Other parts 
of the NHS employ community health workers who work 
out of the GP health centres, covering the patients of that 
practice. This includes most notably district nurses (6,000 
in England in 2012, reduced from more than 10,000 in 2002) 
who visit patients in their homes to dress wounds, provide 
aftercare after discharge from hospital and terminal care. 
It also includes health visitors (about 8,000 whole time 
equivalent [wte] in England in 2012) who provide a universal 
preventive service for every new mother and child, visiting 
mothers in their homes as well as seeing them at the health 
centre. Both district nurses and health visitors are fully 
trained as state-registered nurses (SRNs) with additional 
specialist training qualifications in their areas of expertise. 
Social workers, employed by the local council, may also 
be attached to health centres. Appendix A1 illustrates an 
example of the range of PC services that patients registered 
with a fairly typical group practice health centre have access 
to, free at the point of use.
through referral by GPs. PC therefore needs to be local and 
accessible. Every one of England’s 52 million citizens has 
the right to be registered with a GP, and the vast majority 
are registered (see Table 1). Registration is slightly lower 
for certain groups, such as young adults moving for college 
or work and disadvantaged families living in temporary 
accommodation.
8How GPs are paid for their services: 
GP practices in England are essentially small, physician-
owned businesses that independently contract with the NHS 
(Roland et al. 2012). There are two types of contracts: One 
is a nationally directed contract between NHS England 
and a practice, known as the General Medical Services 
(GMS) contract, introduced in April 2004, with about 
60% of practices on this type of contract. The other is the 
Personal Medical Services (PMS) contract, covering about 
40% of GP practices. The contracts are locally negotiated, 
but heavily influenced by the GMS in form and content) 
(KI:GP). The GMS contract covers three main areas (major 
funding streams):
1. The global sum (otherwise known as core funding), 
which covers the cost of running general practices and 
includes some essential GP services.
2. The Quality and Outcomes Framework, which 
covers clinical and public health. Practices are able to 
choose to provide these services.
3. Enhanced services, which cover additional services 
that practices can choose to provide (NHS Employers 
2014a).
Each of the three areas has its own funding stream, as 
follows.
Funding stream 1: 
The global sum component is largely determined by 
a weighted capitation formula (the Carr-Hill formula). 
It contributes up to 60% of a typical practice’s income. 
Payments are made according to the needs of a practice’s 
patients and the cost of providing PC services, based 
on patient list size, age and sex profile of the registered 
patients and additional ‘need’ indicators, such as mortality, 
morbidity and deprivation of the practice locality. It covers 
diagnoses and treatment of patients for treatable and chronic 
conditions and non-specialist management of patients who 
are terminally ill. Practices have a preferential right to 
provide additional services, and normally do, including 
such services as cervical screening, contraceptive services, 
vaccinations and immunisations, child health surveillance, 
maternity and minor surgery services (NHS Employers 
2013, 2014a, 2014b). Under regulations (e.g. the Health 
Act 2009) that have existed since World War I, GPs can 
provide pharmaceutical services to patients in any locality 
who satisfy the ‘serious difficulty’ test (inability to obtain 
drugs or equipment from an NHS pharmacist because of 
distance or communication difficulties) or who live in a 
controlled locality (at a distance of more than one mile from 
a pharmacy premise) – typically in remote rural areas (DoH 
2012a; Dispensing Doctors’ Association 2014).
Funding stream 2: 
The Quality and Outcomes Framework (QOF) 
component was introduced by the NHS in 2004 as part of 
the GMS, in what was described at the time as a radical 
experiment in healthcare (Roland 2004). It now accounts for 
an average of 15% of a practice’s income. It was designed as a 
payment-for performance (P4P) incentive to improve quality 
of care for chronic disease and to reduce variation in care 
between practitioners (Doran 2006; Whitehead et al. 2009). 
Although voluntary, almost all GP practices in England take 
part. The original system was based on weighted indicators 
related to ten chronic conditions chosen because of their 
prevalence and/or importance in terms of the burden of 
disease (Roland 2004). The indicators and weightings 
have been developed over time. In 2012/2013 there were 
148 evidence-based indicators in four domains: clinical, 
organisational, patient experience and additional services. 
They are listed in more detail in Appendix A2. Practices 
generate points, which lead to payments according to the 
percentage of patients meeting each individual indicator/
target. Appendix A2 shows examples of the 2014 indicators 
for diabetes mellitus. The points are awarded on a sliding 
scale. For each indicator, practices must achieve a minimum 
percentage before receiving points and related payments, 
which increase up to the maximum of the threshold. The 
QOF payment received by a practice is adjusted to take into 
account the practice list size and number of patients on each 
of the disease registers (NICE 2014). 
The QOF allows for ‘exception reporting’, which ensures 
that practices are not penalised when, for example, patients 
fail to attend for review after three invitations from the 
GP, or where a medication cannot be prescribed due to a 
contraindication or side effect (HSCIC 2013a).
Funding stream 3: 
Payments for enhanced services is for the provision of 
optional enhanced services for which practices receive 
additional funding. Previously, the secondary care sector 
provided many of these services. This typically contribute 
up to 15% of a practice’s income, for services that currently 
include:
• Specific schemes: alcohol-related risk reduction; 
learning disabilities health check; patient participation 
schemes; extended hours access;
• Specific areas of clinical practice: timely assessment 
of patients at risk of dementia; identification and 
management of patients identified as seriously ill or at 
risk of emergency hospital admission; and
• Organisational changes: Enabling patients to 
utilise electronic communications for booking an 
9appointment or obtaining repeat prescriptions; 
introduction of remote care monitoring for patients 
(NHS Employers 2014a).
Practices also receive additional income (minor funding 
streams), for example, from NHS CB LATs for costs 
associated with premises, waste collection and maternity/
paternity leave (NHS Employers et al. 2010).
PC - public health links and referral continuity
From the early 2000s to March 2011, Primary Care Trusts 
(PCTs) were responsible for commissioning and monitoring 
PC services in England. Public health directorates sat 
within PCTs and were an integral part of the organisation’s 
function. The 152 PCTs in England were set up as NHS 
trusts, responsible for commissioning primary, community 
and secondary care services for all the residents within a 
defined geographical area – each covering a population 
of about 330,00, on average. In addition, PCTs provided 
public health services and some community health services 
directly. They were collectively responsible for spending 
80% of the total NHS budget. Each PCT had a director of 
public health (crucially with a right to speak out on matters 
affecting the health of the public in the locality, independent 
of the views of the PCT) and a public health team focusing 
on health improvement, assessment of the needs of the local 
population, strategic planning to meet identified needs, 
contributing to the assessment of commissioned services, 
and working in partnership with other agencies inside and 
outside the NHS to tackle social determinants of health and 
health inequalities.
Over the same period, disease control aspects of public 
health were the responsibility of a separate Health Protection 
Agency (HPA), set up in 2003 as a special health authority 
within the NHS to tackle threats from infectious diseases 
and environmental hazards. Local offices of the HPA and 
the public health teams within local PCTs worked closely 
together, but had separate lines of accountability. All 
GPs had statutory duties for the notification of infectious 
diseases to the HPA and other relevant public health bodies.
PCTs also commissioned the range of referral services for 
which GPs were the referring entry point (or gatekeepers). 
These services included secondary and community-level 
care, viz: elective hospital care; rehabilitation care; urgent 
and emergency services; most community health services 
and mental health and learning disability services. PCTs 
commissioned care for all residents in their area, irrespective 
of whether they were registered with a GP.
As noted earlier, CCGs took over this role from PCTs in 
2013 and now commission these referral services for which 
GPs are the gatekeepers. They have a budget of £65 billion 
($110.6 billion) in 2013/4, or 60% of the NHS budget (The 
King’s Fund 2014). There are 211 CCGs altogether, each 
commissioning care for an average of 226,000 people, with 
about 27 GP practices in each specific CCG area. Resources 
for CCGs are allocated by NHS England from a central 
‘pot’ by a weighted capitation formula, which takes into 
account not only the number of patients registered with 
practices in the CCG, but also the age and sex profile of 
the patients, the differing unavoidable costs of delivering 
the commissioned services under local housing and labour 
market contexts (market forces factor), the extra costs 
incurred in delivering services to disadvantaged patients 
and a factor for unmet need (the health inequalities factor) 
(DoH 2013). All GP groups in a geographic area now belong 
to one of these CCGs, with the stated aim of giving all GPs 
a say in decisions on commissioning these referral services 
for their patients.
It remains to be seen how far CCGs take collective 
responsibility for the population in their area, and not just the 
registered patients. It also remains to be seen how potential 
conflicts of interest for GPs managing practice budgets and 
commissioning external services can be avoided.
Prescription charging and exceptions
Prescription drugs are currently subject to a co-payment 
of £8.05 ($13.70) per item but, in 2012, about 91% of all 
prescriptions were dispensed free of charge because most 
patients were exempt from these charges (HSCIC 2013b). 
People entitled to exemptions from charges include: all 
people age 60 or older; people with low income; children 
under the age of 16 years or in full-time education aged 
16–18 years; pregnant women and those who have had a 
baby in the past 12 months; people with cancer; and people 
with certain long-term conditions, and/or disabilities (such 
as permanent fistula, certain forms of hypoadrenalism, 
diabetes insipidus, diabetes mellitus treated by medication, 
hypoparathyroidism, myasthenia gravis, certain forms of 
hypothyroidism, certain forms of epilepsy and people with 
continuing physical disabilities that cannot go out without 
assistance) (NHS Business Services Authority 2014). A 
further 4.2% of prescriptions are paid for with pre-payment 
certificates (cost saving subscriptions for non-exempt 
patients taking regular medication) that cost £29.10 ($49.52) 
for three months and £104 ($176.98) for 12 months with no 
limits to the number of prescriptions/items (HSCIC 2013c; 
NHS Business Services Authority 2012). Less than 5.2% 
of prescriptions therefore incur a charge at the point of 
dispensing.
In 2012 just over 1 billion items were dispensed in the 
community, a 62% increase from 2002, amounting to 2.7 
million items daily. The net ingredient cost of £8.5 billion 
($14.47 billion) in 2012 was similar to that of 2009 and 
marginally (3.2%) less than in 2011. The average annual 
cost of prescribed medicine to the NHS per head of the 
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population thus fell to £159.33 ($271.14) in 2012 from its 
2010 peak of £167.80 ($285.56) (HSCIC 2013b).
The fall in cost may be partly due to the expiry of patents 
for several leading medicines and the use of less expensive 
generic alternatives. The proportion of prescribed items 
dispensed in PC using generics has been increasing in 
the past decade (largely due to the patents expiring for 
commonly used medicines): from 53% in 2002 to 72.7% in 
2012 (HSCIC 2013b). National NHS campaigns encourage 
PC staff and patients to prevent unnecessary prescribing of 
certain drugs, such as antibiotics.
3.3 Social roles in PC
Patient and Public Involvement (PPI) in PC functions 
within a wider NHS PPI context. The NHS constitution 
states that: The NHS will actively encourage feedback 
from the public, patients and staff, welcome it and use it to 
improve services (NHS 2013:3). PPI strategies and systems 
exist within all NHS policy, commissioning and delivery 
organisations from national to local level, including:
• National level: Department of Health; NHS England; 
Public Health England;
• Local level: Local Healthwatch; Local Authority/CCG 
Health and Wellbeing boards; Clinical Commissioning 
Groups; and general practices.
PPI systems also exist within the healthcare quality and 
economic regulatory bodies: the Care Quality Commission 
and Monitor (see www.cqc.org.uk/content/get-involved). 
NICE also has a PPI system (see http://tinyurl.com/4jklwu2). 
The key PPI bodies at local PC level are local Healthwatch 
and GP-enhanced service patient participation schemes.
Local Healthwatches: 
The Health and Social Care Act 2012 created statutory 
responsibilities for local authorities to establish and fund 
Local Healthwatches from April 2013. They replaced 
Local Involvement Networks (LINks) and are independent 
organisations that recruit their own staff and volunteers. 
Government regulation (UK Government 2012) dictated 
that they had to be social enterprises, but did not stipulate 
the forms this should take. Local authorities therefore took 
different approaches to their establishment and funding, 
including open competitive tender, tender waiver and grant 
aid, encouraging consortium bids from the local voluntary 
and social enterprise sector, and transitioning former LINks 
to new health watches, with support from existing voluntary 
sector hosts. Local voluntary sector organisations are either 
members of their local healthwatch or they are involved 
through stakeholder forums (McLeod 2013). The main 
functions of a local healthwatch are:
• Gathering views and understanding experiences of 
service users, carers and community;
• Making people’s views known to service providers;
• Promoting and supporting people’s involvement in 
the commissioning and provision of local healthcare 
services and how they are scrutinised;
• Recommending investigation or special review of 
services via Healthwatch England or directly to the 
Care Quality Commission (CQC) (a statutory body);
• Providing information and advice about access to 
services to support informed choice; and 
• Making the views and experiences of people known to 
Healthwatch England and direction for it to carry out 
its role as national champion (McLeod 2013).
Local Healthwatch bodies have a statutory place on local 
Health and Wellbeing boards, which have formally operated 
since April 2013. Health and Wellbeing boards were set 
up in every local authority with responsibilities for adult 
and children’s services. Their role is to join up NHS and 
local authority decision making and the commissioning of 
certain services. Their minimum statutory members are: 
elected councillors, a representative of each CCG in the 
area; the directors of Adult Social Services; of Children’s 
Services and of Public Health and a representative of the 
local Healthwatch (Regional Voices 2013) The boards 
develop a Joint Health and Wellbeing Strategy (JHWS) 
and a Joint Strategic Needs Assessment (JSNA) that aim to 
improve health and wellbeing in the local community and 
to reduce health inequalities. These form the basis of the 
commissioning plans of CCGs and the local authority (DoH 
2012b) (Further information can be found at http://tinyurl.
com/nhab7hd).
General practice patient participation schemes. 
General practices are entitled to receive additional funding 
to pay for Patient Participation Groups (PPGs) under the 
Local Enhanced Services funding arrangements, although 
key informants indicate there may be changes to this later in 
2014. To receive payment the practice is required to:
i. Develop and maintain a PPG that elicits the views of 
patients and carers and feedback from the practice 
population (through virtual or face-to-face interaction 
or both). PPGs generally include volunteers and 
regular face-to-face meetings;
ii. Review patient feedback received by the practice 
from sources such as a general practice patient 
survey, complaints and suggestions received, local 
voluntary or community groups attached to the 
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practice, Healthwatch, practice champions and peer 
support groups, other local surveys conducted by 
CCGs or Commission Support Units and Care Quality 
Commission reports. The PPG and practice staff 
review feedback at a frequency agreed with the PPG;
iii. Work with the PPG to develop and agree on an action 
plan, based on three key priority areas, and agree how 
the practice will implement improvements; and
iv. Publicise actions taken that affect the practice 
population, including updating the PPG on progress 
and assessment of subsequent achievements within 
agreed timescales (NHS Confederation 2014).
The practice and PPG are required to complete and 
make publicly available a reporting template on actions 
taken during the year, on PPG involvement and outputs 
achieved showing how patients and carers benefited 
from improvements (NHS Confederation 2014). 
An example of this practice is outlined in Appendix 1.3
Voluntary sector support networks. regional networks, 
such as the Voluntary Sector North West (www.vsnw.org.uk) 
support local voluntary sector networks and organisations 
(such as Merseyside Disability Federation, Bolton Society 
for the Blind). They help people understand and navigate 
complex health systems and identify opportunities for PPI in 
decision making. The networks provide key information and 
contacts for the voluntary sector, particularly during periods 
of change such as the recent reorganisation of the NHS in 
England. They also provide opportunities for engagement 
in national level PPI and health policy consultations through 
Regional Voices (www.regionalvoices.org), a voluntary 
sector strategic partner of the Department of Health, NHS 
England and Public Health England (http://tinyurl.com/
p6obw2e).
There are various initiatives reaching out to disadvantaged/
vulnerable populations:
Practice health champions. 
Some practices have specific measures relevant to local 
culture to reach out to disadvantaged groups within their 
catchment areas. One example of this is detailed in Appendix 
1.4. Such organisations, as in the example, train and support 
local people to work with others in their communities to 
improve health. Drawing on relevant expertise, they use 
simple culturally relevant methods to bring local people 
together to participate and work with general practice 
staff, including personalised text and email messages, 
notices in practices and face-to-face contact at school 
gates, community centres, and other local social meeting 
points. The voluntary organisations facilitate contact with 
the PC practices to allow for meaningful participation 
by the community. They explain to other patients how to 
make best use of the practice, how to use the Appointment 
Guide, improving access for those whose first language is 
not English. They are being treated as peers by the practice 
staff and have shown themselves to be a key contributor to 
NHS improvements. Key informants report that their work 
has led to service and quality improvements and service 
redesign (KI: Health Champion Group).
3.4 Patient experiences of PC: 
Diabetes care from patient’s 
perspective
The hypothetical case study character Bob, his wife and 
named healthcare staff are entirely fictional and have been 
created to depict the experience of care from the perspective 
of a patient with a complex chronic health condition. The 
green text highlights Bob’s experience of the system, the 
black text explains it. Appendix 1.5 presents evidence on 
type 2 diabetes in the UK as background to the case.
Bob is a 58-year-old man living in a socio-economically 
deprived area in the North East of England. He works as 
a labourer for a local construction firm but, despite the 
physical nature of his work, he has been overweight since 
his mid-thirties as a result of a poor diet and higher than 
recommended alcohol consumption.
When Bob began displaying some typical symptoms of 
diabetes, e.g. increasing fatigue, thirst and waking at night 
to urinate, his wife Carol encouraged him to see ‘his doctor’. 
He made an appointment with his GP Dr Tom whom Bob 
had known since he was in his thirties. 
General practice patients in the UK traditionally have long-
standing relationships with their GP. This helps to foster 
trust and can reduce consultancy times as GPs are familiar 
with patient histories.
Bob visited his local practice (free of charge) during the 
afternoon after making an appointment via telephone that 
morning. General practice appointments (face-to-face or 
telephone appointments) can be made within 48 hours, 
typically for the same day, or as advance appointments.
He wasn’t a regular visitor to the practice, so at the start of 
his consultation his doctor spent a little time catching up 
with Bob. This reflects a UK GP’s training to consider the 
psychological and social aspects of people’s lives. 
They then talked about his symptoms and discovered that he 
was suffering from mood swings, low energy, dry mouth, 
frequent urination, and more recently hunger after eating 
and headaches. Dr Tom told Bob he suspected he had type 2 
diabetes and asked him to come back the following day for 
a fasting plasma glucose test (and for other blood samples). 
Bob’s blood samples would be taken at the practice (free of 
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charge) before being sent to a hospital laboratory for analysis. 
Tests results requested as urgent are available in a couple of 
days and non-urgent results after two weeks (prioritisation 
by medical need/urgency prevents resources being wasted 
on tests that are not urgent). The results are entered into an 
IT system that sends them to the general practice and makes 
them available to NHS healthcare professionals for future 
use.
The tests confirmed the diagnosis, and the practice contacted 
Bob to come in for another appointment. 
Diagnostic tests are informed by NICE guidelines. Practices 
contact patients when results are positive.
Dr Tom arranged for Bob to be put on the practice’s diabetic 
register and for a practice-based diabetic specialist nurse 
to contact Bob; she would arrange for him to attend the 
practices diabetic clinic. 
His care would be informed by the NICE pathway and 
national care standards. His inclusion on the register entered 
him into the QOF system to ensure appropriate monitoring 
and management of his condition.
Dr Tom also referred Bob to a specialist diabetic team at 
his local hospital and encouraged Bob to take Carol along 
with him. 
People with type 1 diabetes are routinely referred to hospital-
based consultants. However, referral for people with type 
2 diabetes depends on the severity of their condition and 
the resources available at their general practice (e.g. 
specialist diabetes nurses, clinics etc.). Referral is used in 
the case study to illustrate integration of NHS services. 
His first appointment with the hospital-based team would 
be made through the Choose and Book appointment 
system, an electronic referral system that allows patients to 
choose the time, date and place of their first appointment. 
Appointments can be made, or changed, via telephone or 
over the Internet. All appointments and tests would be free 
of charge. Subsequent appointments are arranged at the 
clinic. Family involvement in the management of complex 
conditions is encouraged. In the UK diabetes care is very 
much multidisciplinary (Beresford 2011). Bob would come 
into contact with a range of professionals in an integrated 
diabetic team working across primary, secondary and 
tertiary care, that he would see as one entity ‘the NHS’. The 
team would include his GP, a practice-based diabetes nurse, 
hospital-based diabetes consultant and nurse, a diabetes 
specialist dietician and podiatrist, a local optician for eye 
screening and local pharmacists. An electronic summary 
of his medical records would be available to all appropriate 
healthcare staff.
At his first appointment at the local hospital Bob and Carol 
met his new diabetes specialist consultant and diabetes 
specialist nurse. They talked to Bob and Carol about his 
symptoms and how they were feeling about the diagnosis, 
and advised that they would receive support during this 
difficult time. They performed some further checks on his 
body mass index (BMI), blood pressure, urine sample and 
then sent him to the phlebotomy department for some blood 
samples for further tests. They explained what the tests 
were for and talked about the results that were available 
from all the tests they had received (including from his GP). 
Management of his condition would be informed by NICE 
guidelines (see Appendix 1.5). Test results and information 
from the consultation (e.g. on prescribed drugs, treatment 
plans) would be sent to his GP and the practice would 
contact Bob about these if necessary.
Bob’s consultant explained that the results showed that he 
was borderline obese (BMI = 29.8), his blood pressure was 
high (144/92), his blood cholesterol was high for a type 2 
diabetic (total cholesterol 6.2 mmol/l) and his HbA1c was 
also high (55 mmol/mol). She explained that they would try 
to reduce his blood sugar levels/HbA1c and blood pressure 
at first by improving his diet and increasing his physical 
activity (following NICE guidance), and that he’d be 
supported to do this. If his blood sugar and blood pressure 
remained high he might need to take tablets. In accordance 
with NICE guidance, Bob was prescribed Simvastatin 
to reduce his cholesterol and the chances of heart disease 
or stroke. He would be exempt from prescription charges 
because of his condition (if treated by regular medication).
He was given a three-month follow-up appointment for 
his consultant; later follow-ups would depend on how 
well he managed with support from his general practice. 
Bob’s general practice runs its own (free) nurse-led 
clinics to monitor patients with diabetes. The clinic would 
become Bob’s regular point of contact for monitoring and 
management of his condition to improve his quality of life 
and reduce the chance of complications. 
In addition to core funding, practices receive QOF 
performance-based funding, which helps them to provide 
monitoring and management services for chronic conditions 
such as diabetes. The specific services provided within each 
general practice vary, however. During the next year Bob 
would (annually, as a minimum and free of charge):
• Set management targets for and have his blood glucose 
and blood pressure checked to review them against the 
targets.
• Have his eyes screened, at his local opticians, using 
specialised digital photography to identify signs of 
retinopathy. (NICE guidance recommends that all 
people with type 1 and 2 diabetes are screened for 
retinopathy on diagnosis and annually thereafter. 
The NSF for diabetes introduced a national screening 
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programme based on digital retinal photography. 
Local opticians are private businesses who also 
receive funding from the NHS for screening and for 
free sight tests to certain groups (see: http://tinyurl.
com/kn8g4xb).
• Have his feet, kidney function and BMI checked.
• If he was a smoker, he would have received support 
to quit.
• Attend a diabetes educational course.
• Get specialist psychological support (Diabetes UK 
2012), and
• Received annual flu and pneumococcal immunisations.
Bob managed to lose some weight by improving his diet, 
giving up alcohol and taking some exercise (with the help 
of a free NHS Exercise on Prescription referral service). 
His BMI, blood pressure and cholesterol fell somewhat. 
His blood pressure was monitored at his GP practice every 
three months. He continued taking Simvastatin but was not 
put on medication for his blood pressure. His HbA1c also 
improved, although it remained above the recommended 
limit so he was put on Metformin and given directions to 
gradually increase his dose to minimise risk of gastro-
intestinal side effects (in-line with NICE guidance).
He was provided with free self-testing equipment (for finger 
prick blood tests) by his hospital-based clinic and received 
test strips via free prescriptions. His use of self-monitoring 
reduced over time, and he struggled to know how to respond 
to high readings. Bob and Carol also struggled with the 
complexity of his condition and following all the guidance 
they received, although they appreciated the help they 
received from his diabetic team. 
To address issues of health literacy, the complexity of his 
condition and the integrated health system, Bob and Carol 
may have benefited from additional support from a health 
trainer or practice health champion.
Bob still received care from specialist diabetic professionals 
even when he was later admitted to hospital for a (non-
diabetes related; free) hip replacement (in accordance with 
national standards).
In later life, and because of the adverse impacts of his 
hip problem on his diabetic control (difficulty taking 
exercise), Bob’s optician detected a low/background level 
of diabetic retinopathy. Bob’s (free) screening programme 
was administered by his local hospital. He was referred 
to their specialist eye department for more regular and 
in-depth tests when signs of retinopathy were detected. 
The frequency and nature of the tests intensified with 
the severity of his condition. He received (free) laser 
treatment during the more advanced stages of retinopathy. 
The treatment and closer control of his diabetes, with the 
support of his integrated, multidisciplinary diabetes team, 
prevented further progression of the retinopathy and loss of 
his eyesight.
3.5 Health status outcomes from 
primary care
This section outlines evidence on outcomes of the English 
PC system (with international comparison where available). 
More detailed charts and evidence in the areas covered in 
this section, and particularly on international comparisons, 
are provided in Appendix 1.6.
Mortality amenable to healthcare: 
A death is classed as ‘amenable’ (treatable) if, in the light 
of medical knowledge and technology at the time of death, 
all or most of that cause (subject to age limits if appropriate) 
could be avoided through good quality healthcare (ONS 
2014). Figure 1 shows the pattern of mortality from these 
amenable causes across England in 2012, ranging from 
51/100,000 to 178/100,000. In general, amenable mortality 
rates increase with increasing deprivation, with the deprived 
areas within the north of England experiencing some of the 
highest levels in the country.
Mortality amenable to healthcare has been falling 
dramatically in recent years in England. This is explained 
by a number of different factors. These include increased 
investment in healthcare, improvements in treatment and 
reductions in risk factors such as smoking (Nolte and 
McKee 2011). In England these improvements in mortality 
amenable to healthcare have been greatest in the more 
deprived parts of the country, as a result of which the 
mortality gap between deprived local authorities and those 
in the rest of England has narrowed slightly over the past 
decade, particularly for men (Barr et al. 2014). Barr et al. 
(2014) attributed the observed narrowing in inequalities in 
amenable causes to the government policy (which operated 
from 1999 to 2010) of allocating an increasing proportion of 
NHS resources to deprived areas for the explicit purpose of 
“making a contribution to the reduction in avoidable health 
inequalities” (DoH 1999).
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Figure 1: Mortality amenable to healthcare (death under 75 / 100,000 population) 2012
An international comparative study of trends in amenable 
mortality in sixteen high-income countries from 1997/98 to 
2006/07 found that this remained an important contributor 
to premature mortality in all the countries, accounting for 
about 24% of deaths under age 75. The USA had the highest 
rate of the sixteen countries, with rates almost double those 
of France, which had the lowest levels. Between 1997/98 
and 2006/07, amenable mortality also fell more slowly in the 
USA - by 20.5% - compared with a 34.7% improvement in 
the UK and 42.1% in Ireland (Nolte and McKee 2011). The 
authors concluded that the USA was lagging increasingly 
behind other high-income countries on this measure (Nolte 
and McKee 2011).
Cancer survival: 
Data on five-year cancer survival by socio-economic 
status show a social gradient in survival for some cancers 
in England, with decreasing survival with decreasing 
socio-economic position. Steeper gradients are evident for 
cervical and breast cancer, but not for short-survival sites 
such as lung cancer (Coleman et al. 2001; Rachet et al. 2008; 
Cancer Research UK, 2005). International comparisons of 
cancer survival after diagnosis may be complicated, inter 
alia, by missing data on poorer socio-economic groups in 
some countries (an example of a speculated problem with 
the US data).
Secondary prevention and therapies for coronary heart 
disease: 
A recently published study analysed secular trends between 
1999 and 2007 in the use of key medical therapies in the 
UK (NHS stratified by socio-economic circumstances 
across a broad spectrum of coronary disease presentations, 
including coronary syndromes, secondary prevention, 
and clinical angina). Use of all therapies increased in all 
patient groups, both men and women. Improvements were 
most marked in PC, where use doubled for beta blockers, 
statins, and angiotensin-converting enzyme inhibitors or 
angiotensin receptor blockers for secondary prevention 
and treatment of angina (Hawkins et al. 2013). Small age 
gradients persisted for some therapies, but there were no 
consistent socio-economic gradients or sex differences for 
hard diagnoses. The study concluded that the UK NHS 
is delivering equitable treatment independently of socio-
economic circumstances across a broad range of therapies, 
especially in relation to PC prescribing. There is no room 
for complacency, however, as treatment level still falls short 
of national targets and best-practice cohorts (Hawkins et al. 
2013).
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Quality, access and efficiency of care: 
The Commonwealth Fund conducts regular comparisons of 
health services in the USA and the UK and nine other high-
income countries (Australia, Canada, France, Germany, the 
Netherlands, New Zealand, Norway, Sweden, Switzerland) 
(Davis et al. 2014), as follows:
• In the Fund’s overall ranking of health services, 
the UK ranked first (best), despite spending the least 
($3,405), and the US ranked last (worst), despite 
spending the most per capita on healthcare ($8,508).
• Cost-related problems accessing care: Patients 
in the UK reported the lowest levels of cost-related 
access concerns in terms of the cost of and timeliness 
of accessing care (4% and 6%, respectively).
• Timeliness of care: The UK ranked highly on all 
timeliness of care measures, with patients in the 
UK receiving rapid access (same or next day) to PC, 
reporting the lowest level of difficulty in accessing 
care out-of-hours without visiting a hospital- based 
emergency department and short (under two hours) 
waiting times when they did.
• Efficiency of care: Based on a consideration of total 
national expenditures on health as a percent of gross 
domestic product (GDP), as well as on the percentage 
spent on health administration and insurance, the 
UK ranked top (best) and the US bottom (worst) in 
terms of overall efficiency of health systems. In 
addition, in the UK only 7% of respondents reported 
receiving unnecessary duplicate tests in the previous 
two years (ranked third), compared to 17% in the USA 
(ranked last); and only 16% of UK respondents had 
visited an emergency department for a condition that 
could have been treated by a regular doctor had they 
been available (ranked first), compared to 40% in the 
USA (ranked tenth). However, more adults reported 
rehospitalisation, or a need to visit an emergency 
department after discharge, in the UK (ranked tenth) 
than the USA (ranked fifth).
• Quality of care: In summary, the UK ranked top 
(best) on all four areas of quality of care: effective 
care; safe care; coordinated care; and patient-centred 
care. The USA ranked third, seventh, sixth and fourth 
(respectively) for these measures.
• Equity of access to health services: the UK ranked 
second highest (best) in the overall equity ranking 
for health services, with relatively small differences 
between adults on below and above average incomes 
for most measures. The US ranked lowest (worst) in 
the overall equity ranking with low-income adults at 
particular risk of experiencing poor service.
NHS waiting times – targets: 
Each year the NHS carries out approximately: 250 million 
GP consultations; 14.2 million first outpatient attendances; 
31.1 million subsequent outpatient attendances; 644 million 
diagnostic tests; 1.6 million elective ordinary admissions; 
4.2 million day-case admissions and 4.7 million emergency 
hospital admissions (Goff 2009). All NHS patients have:
• A legal right to start NHS (hospital-based) specialist/
consultant-led treatment within a maximum of 18 
weeks from referral, unless patients choose to wait 
longer or it is clinically appropriate to do so.
• A legal right to be seen by a cancer specialist within 
a maximum of two weeks from GP referral for urgent 
referrals where cancer is suspected (UK Government 
2012a).
In July 2009, 93.6% of admitted patients and 97.7% of 
non-admitted patients were treated within 18 weeks across 
England. The 90% (admitted) standard at the national level 
was achieved for the first time in August 2008 and has been 
sustained in every month since. The 95% (non-admitted) 
standard at the national level was achieved for the first time 
in July 2008 and has been sustained in every month since 
(Goff 2009). More recent (adjusted) referral-to-treatment 
data show that targets have continued to be met – although 
(median) waiting times have increased since January 2013 
to a (post-2007) record low of 90.5% in February 2014. 
The targets for non-admitted patients began to slip in 2013 
with April 2013 being the first time the 95% target was 
missed (94.9% in April 2013). Performance also fell short 
of the same target during eight months between May 2013 
and May 2014, with a (post-2007) record low of 94.2% in 
January 2014 (data from NHS England 2014).
Patient satisfaction with GP services: 
Surveys show high patient satisfaction levels, especially 
for those who have used the service recently (past 12 
months), with 87% of GP users satisfied overall. In the NHS 
England GP Patient Satisfaction survey 2011-2012 (Ipsos 
MORI 2013): 86% of patients responded that the GP was 
good in terms of giving them enough time; 88% of patients 
responded that the GP was good at listening to them; 88% of 
patients responded that the GP was good at explaining tests 
and treatments; 75% of patients responded that the GP was 
good at involving them in decisions about their care, and 
83% of patients responded that the GP was good at treating 
them with care and concern; 64% definitely had, and 28% 
had some, confidence and trust in the last GP they saw. 
Overall rates of satisfaction with the NHS in the general 
population are lower, but still reached a high of 70% in 2010 
following a long period of investment in the NHS. Latest 
figures (2012) show, however, that general satisfaction has 
fallen to 61% following a period of disinvestment in the 
NHS (NatCen 2013).
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4. Promising PC initiatives
A number of PC policy and practice initiatives merit further detail. Those selected have been associated with improved health outcomes and could hold 
lessons for application in the US. They include initiatives to:
i. Incentivise quality improvement and preventive 
activities in PC (Quality and Outcomes Framework);
ii. Improve standards and effectiveness of care for 
patients (the NICE innovation);
iii. Promote the specialist training and status of Expert 
Generalists (GPs);
iv. Improve access and quality of PC in disadvantaged 
areas; and
v. Promote public and patient involvement in decisions 
about PC and the NHS as a whole.
4.1 The Quality and Outcome 
Framework (QOF)
The Quality and Outcome Framework (QOF), when 
introduced into the new national general medical contract 
in 2004, was seen as one of the largest and most radical 
experiments in pay-for-performance for GPs in the world. 
It focuses on prevention, early detection and management 
of chronic non-communicable diseases. It was funded with 
new money as part of the new contract which was, amongst 
other things, designed to improve GPs’ pay and conditions 
relative to hospital-based consultants:
In 2002/2003 when they were putting this contract 
together there was a bit of a crisis in primary care in 
terms of recruitment and retention… and part of that 
crisis was obviously related to the fact that GPs’ pay 
had fallen behind pay for hospital consultants (KI: 
health policy analyst).
The indicators and payment system was discussed in Section 
3.2 and the indicators outlined in Appendix 1.2. There is no 
regular review, but the QOF indicators are currently under 
review and a public consultation is underway (http://tinyurl.
com/738dzro). As a measure to incentivise and support 
quality of care and health outcomes, the QOF is monitored 
in a number of ways:
• Self-monitoring – the QOF IT system automatically 
identifies areas where performance is falling short 
of targets and notifies practice staff, giving them the 
opportunity to concentrate on performance in certain 
areas. Payments, or potential loss of them, incentivise 
practices to self-monitor. Practice managers monitor 
and coordinate responses (e.g. arranging diabetic 
clinics) by relevant staff, including GPs and specialist 
nurses. Integration between the QOF software and 
electronic patient records also alerts healthcare 
professionals if a patient requires QOF-related tests 
during a consultation.
• CCG monitoring of practices – the performance 
information is sent to a central hub and the payments 
are worked out automatically. At the same time, the 
information was also sent via the PCTs, now CCGs, 
to the practices, giving the PCTs the opportunity 
to monitor activities. The PCTs also used to be 
monitored by the [now abolished, regional] Strategic 
Health Authorities: PCTs were the statutory body that 
had the responsibility for ensuring quality of care 
on their patch and now that’s moved to the CCGs… 
So they would say look our PCT compares with this 
one in Cambridge we’re… 5% below on average… is 
there anything we can do to help you, any additional 
training you need. Buy nursing time to send particular 
nurses round to practice to help them hit the QOF 
targets and so on (KI: health policy analyst). As 
previously mentioned, CCGs are now monitored by 
NHS CB LATs (see section 3.1).
• Public reporting – the fact that the performance is 
public is in the public domain and can be looked at is 
actually quite a strong reputations spur for practices 
(KI: health policy analyst).
Most practices reported high levels of achievement for the 
quality indicators in the first year of the scheme (2004-
05), and levels of achievement generally increased in the 
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second and third years, before reaching a plateau for most 
indicators in the fourth year (2007-08) (Doran 2009). Levels 
of achievement were related to the type of activity, baseline 
achievement pre-QOF and the maximum payment threshold 
for the activity (i.e. the level of achievement required to earn 
the maximum payment, which varies from 50% to 90%). 
In 2007/8 the average practice earned more than £120,000 
($204,212) from the QOF, at a total cost to the NHS of £1.1 
billion ($1.87 billion).
The success of general practices in achieving the QOF 
targets in the first year was underestimated. The cost of 
performance payments, approximately £1 billion ($1.7 
billion), was also around £250 million ($425.7 million) 
greater than expected. Additional costs, from the provision 
of IT infrastructure may have brought additional benefits 
to the health system (such as avoiding duplication of work) 
and patients requiring complex, integrated care (KI: health 
policy analyst). Other benefits were noted by Whitehead 
et al. (2009), who reported that although the QOF was not 
designed to address inequalities, by incentivising care for 
chronic conditions, it has the potential to do so. Conditions 
with particularly high prevalence in low socio-economic 
groups, such as type 2 diabetes, may see the greatest 
improvements if improved care is translated into long-term 
improvements in health outcomes. However these benefits 
are not inevitable and Whitehead et al. (2009) also reported 
that improvements in quality of care were not as rapid for 
some ethnic minority groups, warning that the QOF has 
the potential to increase inequalities by diverting attention 
away from other areas of care.
In a review of studies of the QOF in the UK, Steel and 
Willems (2010) found that achievement of the standards was 
high when the framework was introduced and continued 
to increase. For example, improvements were reported in 
diabetes care, and in coronary heart disease, stroke, transient 
ischaemic attacks and blood pressure after the introduction 
of the QOF as well as in indicators relating to smoking. 
However, they also caution that improvements may be 
explained to some extent by pre-existing improvements in 
chronic disease management, a concern others also raised 
(Doran et al. 2006; Eijkenaar et al. 2013). Some studies 
took these underlying trends into consideration and show 
small improvements for some outcomes (such as those 
related to diabetes) (Campbell et al. 2007; Millet et al. 2009; 
Langdown and Peckham 2013).
In general, the QOF has had some positive impacts, 
including on health inequalities and their monitoring:
• Practices that performed worst at the introduction of 
the QOF (concentrated in the most deprived areas) 
improved at the fastest rate. Gaps in the quality of 
PC for conditions including coronary heart disease, 
asthma and diabetes have therefore quickly narrowed 
under the QOF scheme. This may have been facilitated 
by the use of progressive payments that motivate 
practices with a range of baseline achievements to 
improve.
• The provision to exception report preserves the 
clinical autonomy of practitioners, safeguards against 
inappropriate treatment of patients, and ameliorates 
perverse incentives to deny care to ‘difficult’ patients. 
Practices in deprived areas, exception report more 
patients than practices in more affluent areas, but the 
difference is marginal and rates of exception reporting 
have generally been low.
• A comprehensive information technology system 
was established to support the QOF, and most 
practices now use computerised patient records. 
Disease prevalence and quality of care at the practice 
level can now be monitored and linked to a range of 
patient and practice characteristics. However, data are 
not routinely collected at the patient level, and it is 
therefore difficult to measure quality of care by patient 
age, sex and other socio-demographic characteristics 
(Doran 2006).
The QOF may also have had negative impacts, including on 
health inequalities:
• Prevalence of QOF conditions recorded by practices is 
lower than prevalence estimates provided by national 
surveys, a gap that may be greater in more deprived 
areas. Quality of care for ‘missed’ patients is not 
known. Some practices appear to have removed from 
disease registers patients who are unlikely to meet a 
QOF target.
• Quality improvements have not been as rapid for some 
ethnic minority groups.
• Quality of care was already improving before 
introduction of the QOF, and for many QOF activities 
there was only marginal and short-term improvement 
in quality above the underlying trend. Evidence on 
whether improvements in QOF scores are associated 
with improved outcomes for patients is equivocal. 
Given the level of investment in the scheme, the 
opportunity costs in terms of interventions foregone 
need to be considered when analysing the impact of 
the QOF on health inequalities.
• Quality of care for some non-incentivised activities 
was improving before 2004, but does not appear to have 
done so after the introduction of the QOF. There is also 
less training, education and use of guidelines for non-
QOF conditions. Gaps in quality care may therefore 
be developing between patients with QOF conditions 
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and those with non-QOF conditions, particularly in 
practices that had low baseline achievement for QOF-
incentivised activities. Quality is more difficult to 
monitor for non-QOF activities, because data are not 
routinely collected as it is for QOF activities.
• Primary preventive activities may have been neglected 
to some extent in favour of the secondary preventive 
activities prioritised in the QOF.
• The QOF payment system scaled payments according 
to the square root of disease prevalence, rather 
than actual prevalence. Practices with high disease 
prevalence – concentrated in deprived areas – 
therefore received less pay per patient than those with 
low prevalence. This inequitable payment system was 
corrected in 2009.
• Although practices achieve the QOF targets 
corporately, practice partners - usually the most senior 
physicians, distribute QOF payments. Generally, these 
payments have not been equitably distributed among 
all GPs. Practice staff behaviour and the nature of the 
relationship between health professional and patient 
has changed under the QOF, with data gathering for 
quality targets becoming a priority in consultations. 
It is argued to have had limited impact on improved 
health outcomes due to its focus on process-based 
indicators (Langdown and Peckham 2013).
• The nature of the QOF scheme, and the proportion 
of practice income that is tied to performance on the 
QOF indicators, creates a risk that care will become 
more fragmented, efficiency prioritised over genuine 
quality, and professionalism eroded.
• There is a risk of ‘gaming’ of the exception reporting 
system: … it doesn’t matter what system you have, 
people will game it… if you are going to offer a 
financial incentive for doing something within 
medicine you absolutely need to make sure that it 
accords with professional values…. (KI: health policy 
analyst)
• There is also a danger that targets can act as a ceiling 
on continued quality improvement, for example: … 
control of HbA1c [a diabetes management indicator] 
increased quite rapidly and then from 2004 onwards it 
stopped and you can argue that… there’s no financial 
incentive for them to improve because they’d already 
hit the target…. (KI: health policy analyst)
In summary: 
The QOF costs the NHS over £1 billion ($1.7 billion) per 
annum, with a substantial proportion of the money it brings 
into practices invested in senior, general practitioner income. 
It was funded with additional money intended to increase 
GPs’ pay relative to hospital-based doctors (key informants 
suggest that the differential between the two is now on 
average £40,000). There have been substantial additional 
costs relating to the provision of IT infrastructure, although 
its introduction may bring additional benefits.
The QOF was not designed to address health inequalities, 
but by incentivising higher quality, systematic care for 
common chronic diseases it has the potential to do so. Its 
success in this regard is dependent on whether the apparent 
improvements in the quality and equity of delivered 
care under the QOF translate into long-term health gains 
for patients. The QOF also has the potential to increase 
health inequalities by diverting attention away from non-
incentivised areas of care, particularly for practices with 
sicker and more deprived populations that generally have 
greater difficulty achieving QOF targets.
In the first five years of the QOF, payments to practices 
did not fully reflect the level of morbidity in the practice 
population. The payment formula was corrected in 2009, 
so that resources would be better matched to need. To 
prevent QOF thresholds acting as quality ceilings, the 
NHS raised the thresholds for certain indicators in 2013. 
Without professional buy-in and sensitively designed and 
implemented monitoring systems, gaming of the QOF 
exception system may increase.
4.2 Improving standards and 
effectiveness of care: NICE
The National Institute for Clinical Excellence (NICE) was 
originally established in 1999 to improve standards of care 
for patients and reduce inequalities in access to innovative 
treatments (DoH 1999). The initiative was in response to 
evidence of variability in quality of care across the NHS 
and the perception that there was a certain arbitrariness (so-
called ‘post-code’ lottery) in what medicines were available 
and prescribed in different parts of the country. The remit 
of NICE was expanded to public health in 2005 and then to 
social care in 2013 (now named the National Institute for 
Health and Care Excellence – still NICE).
Until 2013, NICE was a statutory Special Health Authority 
within the NHS, and as such was independent of government. 
It became a statutory Non Departmental Public Body from 
April 2013, which is still operationally independent of 
government, although it is funded and accountable to the 
national Department of Health. NICE’s overall goal is stated 
to be: “To improve outcomes for people using the NHS and 
other public health and social care services while ensuring 
value for money” (www.nice.org.uk/about/what-we-do), 
which it addresses through three main centres:
i. Centre for Health Technology Evaluation: technology 
appraisals and interventional procedures, leading 
19
to recommendations on the use of new and 
exciting medicines and treatments within the NHS. 
Technology appraisal guidance covers medicines, 
medical devices, tests to identify diseases, surgical 
procedures and health promotion activities. Based 
on review of evidence on clinical effectiveness and 
economic evidence, which, when combined, leads 
to an assessment of value for money for the NHS in 
England and Wales.
ii. Centre for Clinical Practice: development of clinical 
guidelines on appropriate treatment and care of 
people with specific diseases and conditions within 
the NHS in England and Wales based on the best 
available evidence. The Guidelines (which are 
recommendations, not binding regulations) are used 
to:
 ᵒ Improve the quality of healthcare for specific 
conditions;
 ᵒ Develop standards to assess the clinical practice 
of individual health professionals;
 ᵒ Aid the education and training of health 
professionals; and
 ᵒ Help patients make informed decisions, and 
improve communication between the patient and 
health professional.
iii. The Centre for Public Health Excellence: develops 
guidance on the promotion of good health and the 
prevention of ill health in England. The guidance 
is not restricted to the NHS, but encompasses those 
working in local authorities and the wider public, 
private and voluntary sectors. In all the work of NICE, 
special emphasis is placed on rigorous and transparent 
methods and developing multiple ways of involving 
patients and the public at every stage of the assessment 
(NICE 2005).
The impact of NICE health technology assessments and 
clinical guidelines on specific conditions or procedures 
has been assessed over the fifteen or so years since it 
was established. In the early years of operation, impacts 
appeared to be somewhat variable and modest in PC if 
not accompanied by other supportive actions, including 
impacts on GP prescribing (Wathen and Dean 2004). It also 
depended on whether NICE guidance was implemented 
in practice (Sheldon et al. 2004). More promising results 
were obtained by the twin approach of introducing NICE 
guidelines on Coronary Obstructive Pulmonary Disease 
(COPD) and inclusion of COPD in the new Quality and 
Outcomes Framework (QOF) for GPs, which led to a 
large increase in spirometry data and prescriptions for 
combination inhalers. This represented significant progress 
for people with COPD (Smith et al. 2008). Evaluation of 
single conditions, however, only gives a narrow picture and 
fails to capture system-wide impacts, which arguably have 
been far reaching in some cases.
Wider achievements over past fifteen years:  
The range of system-wide effects of NICE as an institution, 
as well as its products, are impressively wide, and include:
• NICE has standardised care in many areas across the 
NHS – unifying decisions that in the past were made 
in a rather scattered approach;
• Ensured to some extent equity of access to new 
technologies across the health service (though health 
authorities still try to wiggle their way around this in 
one form or another): less now than in the early years;
• Changed the game around making value for money, 
rather than cost of technologies, being seen as the 
prime driver; and
• Helped to change the face of public and patient 
involvement (KIs: GP; evidence-based medicine 
specialist; health policy analyst).
In the past, PC was particularly at the mercy of decisions 
made by individual practitioners and by individual health 
authorities (PCTs). To some extent, NICE, by setting 
standards in a transparent way and by using these as 
benchmarks against which practice can be audited, has 
inevitably improved practice in many areas. These include 
the use of statins in the UK, where the UK is now the second 
highest user in the world after the United States, and general 
markers of cardiovascular benefit, cardiovascular treatment, 
with benefit from that showing a marked improvement.
The negative issues are that the proliferation of NICE 
guidance has, to some extent, removed thinking from 
medical practice. The argument about what is appropriate 
practice has now been superseded by the latest set of NICE 
guidelines, and those are often applied in a rather unthinking 
way:
That’s the frustration because GPs often feel ‘I’m not 
using my judgement in caring for people because I’m 
doing all this bureaucracy on ticking boxes because 
somebody says they’ve read NICE and therefore I 
must do it that way – they haven’t understood that 
it is guidance not rules’. So you have the arguments 
about how do you control the blood sugar in people 
with diabetes? Well the target says it has to be at this 
level and you think, well, actually I think this person 
is having more side effects than they are getting 
benefits if I manage them that tightly…. (KI: GP)
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In addition, NICE recommendations sometimes, in part, 
drive NHS practice and NHS spending into areas that are 
of lower priority. NICE appraisal committees approve 
approximately 90% of all new technologies eventually, with 
considerable cost to the NHS, which may not reflect the 
priorities of a particular area in terms of the disease states. 
Nevertheless, these now become audit standards against 
which all practices are judged and sometimes against which 
practice payments are made. So, the strength of NICE is 
the imposition of national-level standards, the weakness is 
the inflexibility of those standards at times, which may not 
allow a doctor to tailor treatment to the individual patient 
and can often be applied in a very unthinking way.
NICE has brought about these wider impacts in a number 
of ways:
i. Establishing credibility: The body had to establish 
its credibility and in the first instance, one of NICE’s 
early key decisions was refusing the use of Relenza. 
Up until then, there was considerable concern that 
NICE would be seen as being in the pockets of the 
pharmaceutical industry. The rejection of Relenza 
caused a huge political storm, but it also played greatly 
to the independence of NICE as a body – demonstrating 
that it was not simply a rubber-stamping exercise on 
the part of government for increased pharmaceutical 
spending: … it has to have credibility, it has to have 
the support of the professionals and the support of 
government and the support of managers and I think 
one of the great triumphs of NICE has been that its 
achieved all those. I guess it’s done it by the quality 
of its work, by its transparency and by being seen not 
to be in the pocket of any one of those groups. (KI: 
evidence-based medicine specialist)
ii. Making NICE decisions a statutory obligation: A 
pivotal step was the decision by the then Secretary of 
State for Health in 2001 that NICE’s decisions with 
regard to availability of technologies were statutory 
obligations on health authorities. So, if NICE approved 
a device or drug then health authorities had to make 
it available within three months of NICE’s approval 
to any suitable patient residing within its boundary. 
That is a statutory obligation. In the early days, 
health authorities were all testing the water, trying to 
find loopholes in the law. There was a fundamental 
contradiction in the law around the responsibilities of 
health authorities - they may not unjustifiably be asked 
to provide something that they can’t pay for at all 
because they don’t have the money - because at the end 
of the day they have a statutory obligation to balance 
their books, as well as to pay for new technologies. 
There was a tendency for health authorities to try to 
delay or fudge the issue around the availability of 
something approved by NICE. This is less common 
nowadays but it still goes on to some extent (KIs: 
evidence-based medicine specialist; GP).
iii. NICE guidelines becoming audit standards: 
Another important aspect of NICE’s work is the 
development of guidelines for the care of a variety 
of conditions: currently amounting to some 170 or so 
odd different guidelines. Even though these guidelines 
are not backed by a statutory obligation, they have 
been seen as authoritative, to such an extent that they 
have become an audit standard for practice: health 
authorities are expected to use them as audit standards 
as are individual practices. In effect, NICE guidelines 
have become benchmarks against which practices are 
judged.
iv. Playing on professional obligation: NICE guidelines 
have become audit standards, even if not compulsory 
due to the paradigm of evidence-based practice that 
has been growing in the UK since about 1990. Arising 
from that is the development of evidence-based 
guidelines or, in the absence of complete evidence, the 
best consensus that can be achieved using the evidence 
available. In the UK in the 1990s, there were a large 
variety of guideline providers, sometimes using 
competing guidelines and that’s still the case today. 
But NICE has established itself as the main producer 
of evidence-based and quality guidelines within the 
UK, strongly supported by government ministers. It 
would be considered a professional obligation. It is 
open to practitioners to argue a particular case if the 
NICE guideline was wrong or not to follow it at all, but 
the doctor who does that really leaves himself open 
to managerial criticism and possibly to medical legal 
challenge. … and services have increasingly been 
configured to deliver NICE guidelines so, for instance, 
if NICE guidelines recommend that a patient be seen 
within two weeks, health authorities start to move 
their services to meet that criteria. (KI: evidence-
based medicine specialist)
Influence on prescribing, generics and the medicines bill: 
NICE cannot be credited with reducing prescribing or the 
switch to generics, as these trends had been well established 
in the UK since the early 1990s. The transition to generic 
prescribing was essentially complete by 2000 and arose 
out of a range of government schemes that all pre-date 
NICE, starting with the indicative prescribing scheme (see 
Bligh and Walley 1992) of 1990 onwards and its various 
derivatives. NICE would not give opinions on generic drugs 
because it only looks at new drugs. There are other cultural 
drivers, though, in addition to the various government 
schemes:
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There is an inherent conservatism in use of new 
drugs in the UK. Practitioners are loathed to use 
new drugs and that’s based on bitter experience over 
many years - new drugs not fulfilling the benefits 
they’ve been claimed to have and subsequently 
demonstrating substantial adverse effects. So there’s 
a strong memory of that which predicates UK 
practice and makes us reluctant to leap onto new 
drugs for the most part. That has existed since the 
1960s, so it’s not a new phenomenon in the UK (KI: 
evidence-based medicine specialist).
The main reason the national medicine bill has decreased is 
that many of the major blockbuster drugs have now come off 
patent. Back in the early 1990s, the medicine bill was rising 
by 10-15% per year, with effective new medicines coming on 
the market like statins. Twenty years on, these medicines are 
coming off patent and the rate of pharmaceutical innovation 
has declined substantially, making that kind of mass use 
blockbuster medicine rare nowadays. There are numerous 
expensive medicines in particular areas but the vast bulk 
of prescribed medicines are not novel, most are off patent, 
which lend themselves to generic prescribing as well.
The UK experience contrasts with that in many countries, 
in which the practice of generic prescribing has never taken 
off, so that drugs are prescribed by brand name. There hasn’t 
been the same culture of hesitancy on the part of doctors in 
those countries to prescribe new drugs, though a shift in this 
hesitancy may also be building in the UK:
There has been a shift in the UK in the past 20 
years in the willingness of patients to take drugs. 
We’ve certainly seen a large increase in volume of 
prescribing in the UK in the past 20 or 30 years, in 
part driven by all kinds of investment, increase in 
numbers of GPs and emphasis on evidence-based 
medicine, a rise of the paradigm of preventive rather 
than treatment. In particular in primary care, so the 
volume of prescribing has increase enormously in the 
UK but because the drugs being used are relatively 
inexpensive the costs have not risen to the same 
extent. (KI: evidence-based medicine specialist)
Cultural differences are also evident: Dutch people 
are notoriously reluctant to take drugs and drug use is 
relatively low in Holland, prescribed drug use at least. 
Whereas the French are notoriously keen to take drugs…
drug use is hugely variable in the States because of course 
many patients in the United States will have to make co-
payments of one kind or another far more than in Europe or 
far more than in the UK for instance. (KI: evidence-based 
medicine specialist)
As noted in previous sections, in the UK the prescription 
charge is levied on less than 10% of all prescriptions, so 
the vast majority of prescriptions have almost no co-
payment. In a relatively disadvantaged city, only about 2-3 
% of prescriptions actually carry a co-payment of any kind. 
Economic pressures on the use of medicines are therefore 
less evident in the UK than they are in the United States.
Culture and the principle of ‘free at the point of use’: 
Because all NHS services are free at the point of use and 
under 10% actually pay for any prescriptions, economic 
theory would predict over-use, so why isn’t that the case?
I think we should explore culture a bit more as 
an issue because I think the national service was 
founded at a time when the sense of national unity 
was probably much stronger than it is now and the 
paradigm of free at the point of delivery, which was 
established then, has been maintained. But I think it 
is creaking in the face of rising consumerism. So one 
finds quite different patterns amongst older patients 
for instance, who talk about being embarrassed at 
occupying a hospital bed that other people might 
need, whereas younger patients see it as their 
right. So they’re very generational differences and 
slippages between responsibilities and rights as 
consumerism is on the rise and I’m not sure how 
well the model of being free at point of delivery will 
actually survive the rise of consumerism if people 
see it as their right to demand services. So I think 
that’s going to change over the course of the next 20 
years in the UK, so I think that culture of national 
unity is still quite strong. You know there is a sense 
as one politician has commented that the NHS is 
Britain’s national religion and cannot be criticised 
and everyone must bow to it in one form or another 
in contrast to other countries. (KI: evidence-based 
medicine specialist)
NICE’s influence on equity of access: NICE’s aim is to 
improve geographic equity by improving the spread and 
reach of new, effective technologies around the country. If 
NICE decrees that a specific technology will be available 
everywhere in the country, that may be relatively easy for 
most drugs, but for other technologies, it may not help at all 
and may generate other inequalities:
You simply can’t provide the services to someone 
in the Western Isles that are available to someone 
in London, that’s never going to happen and the 
same is true to some extent of the availability of new 
technologies. There is more to it than geographic 
equity. There’s also knowledge, understanding, 
education on the part of the patient about what’s 
available, what they can ask for and by putting 
money into expensive technologies that perhaps 
inevitably are used more by better educated and 
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more well-healed elements of society, they are 
actually decreasing equity across society. (KI: 
evidence-based medicine specialist)
International influence: 
The pharmaceutical industry’s main concerns with NICE 
are less around its influence on the UK market and more 
around its visibility internationally. The UK has around 
3% of the world pharmaceutical market. If a company 
doesn’t get a foothold in that market, 3% doesn’t matter in 
the grand scheme of things. But the influence of NICE and 
its appraisals go round the world and have a huge influence 
internationally on what the potential market for a product is. 
Companies are very aware of that influence. Why NICE has 
that influence is an intriguing question:
I think the British model, particularly in relation 
to drugs, is one that’s been widely admired 
internationally in relation to the quality, for instance, 
drug regulation and drug licencing initially and then 
as the paradigm has shifted more towards regulation 
of availability and regulation of price. NICE’s 
approach has become very influential internationally 
because of its transparency and quality of its work. 
Perhaps less because of hard evidence it has actually 
made a difference to how much you spend on things. 
But I think countries all over the world suffer and 
struggle with this….So NICE has been influential, 
not in making national decisions in other countries, 
but certainly something that everyone looks to 
before they make a decision in most countries. (KI: 
evidence-based medicine specialist)
Instead of setting up its own NICE, a country may use the 
work of NICE adapted to their own local circumstances, by 
using the data it provides, for instance, and factoring in local 
patterns of disease and care. Most European countries look 
at NICE very carefully in this way.
4.3 Promoting the training and 
status of Expert Generalists
One of the features of the UK PC system is that general 
practice is treated as a specialism, requiring the depth of 
training of secondary care specialties. There have been 
continued attempts to raise the income levels of GPs to 
that of hospital consultants. These and other features of 
the system have raised the status of general practice and 
facilitated favourable public attitudes to PC and its trusted 
role as entry point to the referral system.
Explanations for this go back to a model of PC that derived 
from the national insurance scheme before World War I, 
strengthened after that war and then, in 1948, the NHS that 
promised that each person would have their own named 
doctor who was responsible for him or her all the time. 
That ideal has been watered down over the years, and it is 
now the general practice, rather than the individual GP, that 
has responsibility for each registered patient, with concern 
raised by a key informant from PC practice that there is a 
loss of personalised care (KI: GP). At the same time the 
general principle remains of a long-term doctor-patient 
relationship and continuity of care, one that was also noted 
to demand a higher level of training (KI: GP).
Issues of training clearly play a part in acceptability and 
trust in general practice. Training to become a GP in the 
UK takes a total of ten years. All medical schools offer GP 
specialty training programmes (The National Recruitment 
Office for GPs 2012a). GP training involves:
• A five-year undergraduate medical degree – studying at 
a medical school attached to a university, with clinical 
placements in hospitals and the community. For the 
initial medical training, the NHS allocates a specific 
number of places to each medical school to meet 
national workforce requirements for all specialties. 
Prospective students apply to the medical schools of 
their choice and are selected on their academic record 
and assessment of aptitude.
• A two-year foundation programme (F1 and F2) of 
general medical training that must be completed by all 
medical graduates before further training.
• Three years of specialist training in general practice 
to gain membership in the RCGP. The standard route 
for most trainees is via a Certificate of Completion 
of Training that is awarded to doctors who have 
successfully completed a General Medical Council 
approved programme (RCGP 2014).
• Then there are schemes whereby young, qualified 
GPs continue to learn together in groups and run their 
required continuing professional development (CPD), 
supported by senior people in the practice and from 
the RCGP (NHS Careers 2014).
The NHS funds the specialist training of GPs, as with 
other medical specialities. GP trainees are selected 
through a national GP selection system (described by The 
National Recruitment Office for GPs [2012b] here: http://
tinyurl.com/ou44ajf). As with other UK students, medical 
undergraduates pay tuition fees (£9,000/$15,300 a year), 
although their education is heavily subsidised by the 
government and (as with other disciplines) students receive 
loans to cover tuition fees so that no upfront fees have to 
be paid. Students from disadvantaged backgrounds may 
also apply for bursaries to cover tuition fees. The NHS pays 
medical trainees a salary during the F1 and F2 foundation 
years after graduation with a medical degree. Once a trainee 
has been accepted by the national GP training scheme, the 
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NHS pays them a salary for the duration of the training (KI: 
medical education).
NHS workforce planning, which covers 101,000 general 
practice staff (of 1.3 million NHS staff – based on 2011 
data), is supported by Health Education England, a national 
body that provides system-wide leadership and oversight of 
workforce planning, education and training of all healthcare 
staff (Health Education England 2014). Long-term 
workforce planning is designed to ensure that the correct 
proportion of GPs, relative to other specialities, are trained 
and recruited at national and local levels; the same applies to 
other PC professionals. In recent years, as a result of a drive 
towards healthcare in community/PC settings, the numbers 
of GP training vacancies have increased. In 2013, 98% of the 
3,921 declared vacancies in 2013 were filled (The National 
Recruitment Office for GPs 2013).
Specialist training has been characterised as fundamentally 
about managing uncertainty: learning how to make 
informed decisions about whether a condition is minor and 
self-limiting, minor and long-term, major but getting better 
and major but dangerous:
It’s the major and dangerous that you have to make 
sure you haven’t missed, as well as a potential cancer 
or a potential serious heart disease or whatever else 
it might be, and so we’re having to sort of balance 
those things. Managing uncertainty is what the 
training is about. (KI: GP and trainer)
GP training is designed to encourage practitioners to 
consider care as a whole, from health promotion and 
prevention to palliative care. Expert Generalists is the term 
the RCGP uses to characterise the specialist nature of the 
profession.
This depth of training has encouraged a high level of trust 
of PC as the first port of call for someone seeking care and 
as respected entry point for referral to secondary care, as 
gatekeeper. With the 90% of healthcare contacts in the NHS 
dealt with in PC, as noted earlier, this gatekeeper role could 
not function effectively if people did not believe that GPs 
had the necessary expertise to help them get the care they 
need.
GPs’ expertise in managing uncertainty is also argued to 
reduce unnecessary medical investigations and diagnostic 
tests, as they use their clinical judgement to a fuller extent 
(KI: GP). Professional values and public service ethos 
are further pieces in the jigsaw puzzle, fitting together to 
influence affordability, efficiency and effectiveness of the 
system as a whole:
It’s the individual moral beliefs of the practitioner 
that make this work or not work. We do this work 
because we want to provide good quality care. 
If you have a financially driven model, to use the 
technical term, you’re screwed. Because I think then 
you have people that say no, it’s 5 o’clock, my shift 
is over, sorry I’m not seeing any extras, rather than 
“have you seen how busy it is the waiting room? It’s 
heaving. I’d better stay an extra half hour.” … that’s 
how you have to be able to work. You have to believe 
that what you’re doing is about caring for people. 
(KI: GP)
How far this ethos can be transplanted into a different 
culture, and how much longer it can be maintained in the 
UK in the face of privatisation, are critical questions in the 
current climate.
4.4 Initiatives to improve access and 
quality of PC in disadvantaged 
areas
Before the establishment of the NHS in 1948, there were 
great differences in the density of GPs, with three- to fourfold 
differences between affluent and poorer areas (House of 
Commons Debates 1945-1946). One of the successes of 
the NHS is argued to be the achievement of a much fairer 
distribution of GPs, which corresponds much more closely 
to the size of the local communities (Benzeval and Judge 
1996). These distribution problems have not been entirely 
solved and progress may have stalled or inequalities widened 
in recent decades (Benzeval and Judge 1996; Gravelle and 
Sutton 2001; Hann and Gravelle 2004; Goddard et al. 2010). 
The maldistribution of GPs has been a continuing national 
policy concern for decades, made famous by Julian Tudor 
Hart, a longstanding GP in disadvantaged mining valleys 
of Wales, who coined the Inverse Care Law from his 
experiences in general practice throughout the 1960s:
The availability of good medical care tends to vary 
inversely with the need for the population served. 
This inverse care law operates more completely 
where medical care is most exposed to market forces, 
and less so where such exposure is reduced (Hart 
1971).
Three main policy instruments were used to encourage 
a fairer distribution of PC practices around the country: 
controlling where doctors can set up new practices; offering 
incentives to work in disadvantaged areas; and increasing 
the supply of GPs overall in the country. The experiments 
have had varying success.
i. Entry control: From 1948 to 2002, the English 
Department of Health, through the Medical Practices 
Committee, restricted entry by GPs into areas 
classified as over-doctored. In 2002, the controls 
were abolished in England, followed by Scotland in 
2003, thus providing a natural policy experiment. 
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Impact assessments conclude that such entry controls 
had a weak but positive impact on reducing the 
maldistribution of GPs, particularly in the early 
decades of the NHS, with a sharp deterioration in 
equity after they were abolished (Goddard et al. 
2010). Entry controls were found to be insufficient in 
themselves to prevent the deterioration in equity that 
was observed between mid-1990s and the abolition 
of controls in 2002 and to be a blunt instrument to 
achieve improved outcomes (Goddard et al. 2010).
ii. Targeted incentives to practice in under-doctored 
areas. From 1990 to 2004, through the General 
Medical Contract for GPs, capitation payments for 
registered patients from deprived areas were increased 
relative to those for patients from other areas (known 
as the underprivileged area, UPA 8, payments) (Carr-
Hill and Sheldon 1991). While the payments increased 
the GPs’ income in disadvantaged areas with the same 
number of registered patients, its overall effect in 
attracting GPs to under-doctored areas is uncertain 
(Gosden et al. 2001), possibly due to the interaction 
with the entry controls in over-doctored areas over 
the same time. Some of the GPs attracted into under-
serviced areas by incentives may have come from 
other under-served areas, exacerbating, rather than 
improving, the maldistribution (Goddard et al. 2010).
iii. Increasing the total supply of GPs. From 2002 to 
2005, England experienced an unprecedented increase 
in the supply of GPs, with an increase of 12.7% GP 
whole-time equivalents per capita, compared with a 
decrease of 0.1% in the preceding four years. Scotland’s 
supply grew more slowly over the same period. This 
increase in per capita supply between 2002 and 2006 in 
England was not significantly associated with changes 
in health or facility outcomes (Goddard et al. 2010). 
However, the widening inequalities after the 2002 
abolition of entry controls was less rapid in England 
than in Scotland, possibly because England had a 
sharper increase in the rate of growth of GP supply 
after abolition than that experienced in Scotland 
(Goddard et al. 2010).
Overall, it appears that GPs’ motivations for re-location 
need to be more fully understood to design effective 
remedies for their maldistribution. There is some evidence 
that GPs in England prefer to locate in areas with lower 
deprivation levels, a more pleasant environment and higher 
levels of amenities (Goddard et al. 2010). Push factors 
from areas of higher deprivation may not solely relate 
to personal income, but also to the stress of working in 
deprived areas, and the extra workload from dealing with 
more severe illness, early onset of chronic disease and 
higher prevalence of multimorbidity in more disadvantaged 
practice populations. Two initiatives that have tried to take 
account of the complexities faced by PC in disadvantaged 
areas are described below with further detail and further 
key informant quotes provided in Appendix 1.7.
Delivery of PC in the most deprived areas – GPs at the 
Deep End (Scotland):
GPs at the Deep End comprise about 360 GPs working in 
general practices serving the 100 most deprived populations 
in Scotland. Before the group was established in 2009:
…they had never been convened or consulted by 
anyone since the start of the NHS. Since then, it 
has established a strong identity for this group, a 
coherent statement of the problems faced by primary 
care in very deprived communities and a strong 
and consistent message, expressed via reports and 
lobbying, for what is required to improve health in 
very deprived areas. (KI: Deep End GP)
The initiative is based on the premise that the best people to 
know how to improve PC services in disadvantaged areas are 
the people living and working in these circumstances. Deep 
End practices have identified multiple supply and demand 
issues within the most deprived practices, which include: 
higher demand on services; shorter time availability; 
greater GP stress; less enablement reported by patients with 
problems and a higher prevalence of physical, psychological 
and co-morbidities/multimorbidity, with these problems 
concentrated within families, practices and areas (GPs at the 
Deep End 2009; Watt 2002). Tudor Hart’s cartoon (Figure 
2) presents Graham Watt’s Deep End swimming pool 
analogy. While the prevalence of health problems rises 2.5-
3-fold across the socio-economic spectrum, the distribution 
of GPs is almost flat. In severely deprived areas this results 
in a major mismatch of need and resource, with insufficient 
time to get to the bottom of problems – hence GPs at the 
Deep End struggle to tread water. GPs in affluent areas are 
standing in the shallow end with their feet on the bottom. 
This analogy does not imply that GPs at the shallow end are 
not busy, or that they do not have demanding patients, but 
their patients generally live much longer and present less 
complex burdens of need (Watt 2012).
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Figure 2: GPs at the Deep End
Source: Julian Tudor Hart in Watt G (2012), with permission from JTH.
Their initial meeting, half funded by the Scottish 
government, was attended by GPs from 70 practices. The 
experience and views of the GPs and their patients were 
captured and summarised during a series of meetings that 
were, after the initial meeting, led by a steering group. From 
their first fifteen meetings (2009 to 2011) they produced 
fifteen reports covering a wide range of issues in a language 
that was non-jargon, acceptable to the participants and 
also meaningful to us (KI: Deep End GP) (see list of reports 
in Appendix 1.7). The reports attracted interest from the 
British Journal of General Practice, which serialised 
twelve articles in 2011-2012 as a resource for practitioners 
and policy makers. They have now produced a further nine 
reports addressing particular Deep End practice issues 
(such as integration of care, access to specialists and the 
impact of government austerity policies on patients and 
GPs) that synthesise the lessons learned across the initiative 
on preventing and mitigating health inequalities (KI: Deep 
End GP). (All available at http://tinyurl.com/a2bzubp).
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A March 2013 report ‘What can NHS Scotland do to 
prevent and reduce health inequalities? Proposals from 
General Practitioners at the Deep End’ summarises both 
the issues faced by the Deep End practices in Scotland and 
their proposals for solutions, detailed in Appendix 1.7. In 
summary the challenges relate to:
• The higher prevalence of multimorbidity and special 
features of health need in deprived communities, 
including mental health and addiction;
• The lack of clinical capacity in PC practices serving 
deprived areas to address these problems with 
fragmented care; dysfunctional links between PC 
practices, area-based services and secondary care; 
a disconnect between PC teams’ knowledge and 
experience of patients and their use of community 
resources for health; and a lack of opportunity for PC 
teams to share experiences, views and practice;
• The failure of many centrally led NHS initiatives to 
engage effectively with PC;
• The paucity of research evidence on the work of 
general practice teams in deprived areas; low profile 
of most central NHS support organisations; and
• The need for training, continuing professional 
development, leadership development amongst health 
practitioners working in deprived areas and a new 
relationship between NHS leadership at area and 
practice level. (GPs at the Deep End 2013).
The initiative made proposals for improving PC practice in 
these areas, to:
• Give time for consultations with patients and targeted 
appointments for the neediest patients;
• Support for serial encounters and long-term 
relationships;
• Attach staff from area-based services (social work, 
mental health, addictions, child health) to PC practices, 
individually or as groups and connect practices and 
patients with community resources for health;
• Support for training and leadership development 
within and between practices and linked to locality 
planning;
• Protected time for practices to share experiences, 
information, learning and activity on a cluster basis; 
and for a new partnership between leadership at 
the top and bottom of the NHS, based on mutual 
understanding, accountability and respect;
• Evaluation and research based on and informing the 
person-centred work of general practice, especially in 
deprived areas; and
• A greater focus by central NHS agencies on supporting 
PC serving deprived areas, beginning with an audit 
of what these agencies currently do. (GPs at the Deep 
End 2013.)
The work is ongoing and is supported by the Royal College of 
General Practitioners (Scotland), the Scottish Government 
Health Department, and General Practice and PC at the 
University of Glasgow. Plans are underway to introduce a 
similar initiative in England.
PC services to homeless people: 
A further example of a general practice reaching out 
to vulnerable patients comes from a practice based in 
a deprived inner-city area of northern England, which 
provides dedicated services to homeless people. The GPs 
that established the general practice in the 1990s recognised 
that homeless patients were not being looked after in PC. 
When they did receive care it would be via local A&E 
departments. The GPs had a ‘special interest’ in providing 
the service, which, over time developed into a practice-wide 
ethos, securing funding to develop the services further (KI: 
practice manager). The funding, coming from Enhanced 
Service funding (£90,000 a year) is used almost entirely 
to employ two advanced nurses. The practice works with 
homeless people, one of three main population groups it 
serves. It runs a homeless access clinic one afternoon every 
week, closing its regular clinic at that time, and providing 
a one-stop-shop for homeless people. The clinic is staffed 
by two GPs, two nurses, a substance misuse counsellor 
(drug worker) and a healthcare support worker. Nurses 
who specialise in hepatitis C and in alcohol abuse are also 
employed. Hostel and practice outreach staff encourage and 
support homeless people to attend for help with specific 
health problems and to receive advice, support, screening 
and treatment for a wide range of health issues (KI: practice 
manager). The two practice-based nurses (paid through the 
Enhanced Services funding) also do a lot of outreach work 
in homeless hostels and to homeless patients when they are 
in hospital, including talks to patients and hostel staff.
…All the hostels have the homeless nurse mobile 
number and ring it really regularly with… [such as] 
‘I’ve got John Smith here and I’m a bit worried his 
leg looks a bit red what do you think I should do?’ 
So that kind of contact is really useful in order to 
manage the patients in the best way, otherwise their 
main source of care would be A&E… (KI: practice 
manager)
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They work together with hostel staff to identify new patients 
who have not engaged with health services to encourage and 
support them to attend the clinic. The GPs and nurses also 
go out to patients who are reluctant to engage with health 
services to provide services directly, and to encourage 
future engagement. Using money from the Enhanced 
Service funding, the practice contracted a local homeless 
charity to provide a waiting room mentor who has personal 
experience of being homeless and who supports the 
interaction in various ways, including to manage conflict or 
advise on services:
… he engages with these patients on a level that 
we would never be able to engage in because we’ve 
not got that lived experience and he’ll direct them. 
So he has one-to-ones with patients in terms of… 
supporting them, offering interventions, offering 
advice, linking patients in with different services. 
(KI: practice manager)
The patients’ circumstances mean that the practice has to 
provide a flexible patient registration process, given that 
clients have no fixed abode, liaising with other homeless 
services that they connect with for their contacts and 
dedicating substantial resources to case management (KI: 
practice manager). Staff receive specialist training for this, 
including customer care and social communication.
The key informant described an analysis (conducted two 
years previously by the former PCT) of the health service 
resources that the practice’s homeless patients used. Before 
the clinic, despite there only being 800 homeless patients 
compared to 28,000 non-homeless patients, the homeless 
accounted for 21% of emergency care admittance, largely 
for conditions that should be managed effectively in PC, 
raising the costs of care to the NHS and to themselves. 
The full costs and benefits are yet to be assessed, but, as 
an indication of the financial protection, the support by an 
alcohol nurse reduced the costs to the NHS for one patient 
by £34,000 ($57,800) by preventing the need for hospital 
emergency care (KI: practice manager).
Rigid/inflexible performance targets designed for the general 
population cannot be applied to this population group: [the 
group of patients] messes up our targets something awful 
so… we get measured on the percent of patients with those 
conditions who go to, who are admitted to hospital and 
we’re red on… 4 out of 8 targets. (KI: practice manager)
There is, however, sufficient discretion in the current 
performance target and funding systems. All general 
practices are funded to provide an enhanced service (the GP 
specification) that provides top-up funding, on top of core 
funding, to ensure that every practice gets the same level of 
funding per patient. They have to meet ten key performance 
indicators (such as A&E attendance, in-hours attendance, 
flu vaccinations, out-patient referrals) to access the full 
funding. The system gives the practice the opportunity 
to provide evidence annually to the GP spec’s validation 
committee so they can demonstrate their efforts and why 
they may be missing certain targets. This has helped to 
protect their income (KI: practice manager). National 
performance and QOF payment systems, as noted earlier, 
also provide some room for discretion based on the needs 
of particular patients. Using this space depends in part on 
the practice finding innovative ways of providing services, 
while meeting targets and reducing the need for exception 
reporting (KI: practice manager). Further information is 
contained in Appendix A7.2.
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5. Managing and sustaining 
change in PC
S everal mechanisms for managing and sustaining change in PC have been built into the processes and systems described in this paper, including:
i. Monitoring and oversight of ‘payment for 
performance’ incentives to improve quality and 
secondary prevention in PC, through the Quality and 
Outcomes Framework (QOF) - see Section 3.6.
ii. Monitoring of referral rates of PC practices and setting 
targets for change where appropriate.
iii. Fulfilling statutory obligations on PCTs/CCGs to make 
available to any suitable patient within their boundary 
any device or drug approved by NICE, within three 
months of approval. This is a mechanism for improving 
geographic access to effective technologies, but it also 
acts as a brake on the prescribing of drugs or other 
therapies that have not been approved by NICE, as the 
PCT/CCG has no obligation to authorise payment for 
non-approved items (see Section 3.7).
iv. Monitoring and holding to account for the meeting of 
national targets on a range of outcomes, including on 
efficiency savings, waiting times, prevention, health 
promotion and health inequalities improvements. 
Some of the targets have carried financial penalties for 
failure to achieve targets, while others have attracted 
additional resources to help achievement. PCTs 
themselves, for example, were allocated additional 
resources from the central NHS budget, based on the 
level of mortality and deprivation within their resident 
population, to assist in meeting health inequalities 
reduction targets (see section 3.2, How GPs are paid 
for their services).
v. Parliamentary scrutiny: Several parliamentary 
committees and independent auditing bodies operating 
at national level scrutinise the operation of parts of the 
NHS and public health function fairly regularly. These 
include the House of Commons Committee of Public 
Accounts, which investigated ‘Tackling inequalities 
in life expectancy in areas with the worst health and 
deprivation’ in the 2010-11 session; the Parliamentary 
Health Select Committee, which investigated what the 
NHS was doing about health inequalities in 2006 and 
2010 and on resource allocation to PC in 2012; and the 
National Audit Office. The bodies under investigation 
take seriously the findings of all such investigations.
This paper also gives an insight into the ideas, individual, 
institutional factors and the interests (professional, social, 
political and other) that have supported PC innovation or 
sustained promising PC practice. These are summarised in 
Table 4:
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Table 4. Factors that promote, sustain, or act as barriers to PC innovation
Factors that promote and sustain or act as barriers to change in primary care 
systems
Institutional (policy/ 
system or practice level) Ideas Interests External events
Facilitators Policy legacies: 
Fundamental design of the 
NHS universal healthcare 
system within which PC 
is embedded: universal 
entitlement, financing 
through general taxation 
(progressive), services 
free at the point of use, 
comprehensive healthcare 
coverage, equality of 
geographic access, high 
standards of care for all, 
selection on the basis of 
need and the encouragement 
of a non-exploitative ethos.
Policies and systems: 
Comprehensive patient 
registration and information 
systems.
Common resource allocation 
and GP contract (core, QOF 
and enhanced services 
funding).
Statutory duty on health 
authorities to make available 
health technologies approved 
by NICE.
Making GP a specialty and 
increasing remuneration of 
GPs.
National system of workforce 
planning and NHS funding of 
specialist training of GPs (as 
it does for other specialties).
PPI systems involve public in 
system redesigns.
Culture & ethos: 
Public and political 
support for NHS 
since founded in 
1948.
General ethos that 
patients should not 
be exploited for 
profit.
High GP status.
High patient 
satisfaction and 
trust.
Government 
introduction in 
1999 of additional 
objective for NHS 
resource allocation 
“to contribute 
to reduction in 
inequalities in health 
status”.
Evidence-based 
medicine movement 
gaining pace in the 
in 1990s – played 
a role in stimulating 
the setting up of 
NICE.
Acknowledgement 
in early 2000s of 
evidence that GPs’ 
income had slipped 
behind doctors in 
secondary and 
tertiary care.
Acknowledgment 
amongst the 
public health/
health inequalities 
movement of the 
inverse care law and 
need for equity of 
access to healthcare.
Improved fiscal 
climate during 
early 2000s 
providing funding 
for increased NHS 
investment.
Evidence from 
international 
comparisons 
showing lower 
percentage of UK 
GDP being spent on 
NHS in comparison 
with other EU 
members - leading 
to government 
commitment in early 
2000s to increased 
funding for NHS 
towards European 
average.
Ageing population 
and increasing 
prevalence of 
chronic health 
conditions.
Increasing costs of 
health technologies 
driving need for 
efficiency.
Evidence of 
substantial 
socio-economic 
inequalities in health 
status affecting 
need for additional 
services and driving 
search for equitable 
resource allocation.
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Factors that promote and sustain or act as barriers to change in primary care 
systems
Institutional (policy/ 
system or practice level) Ideas Interests External events
Barriers UK treasury 
resistance to 
increased spending 
on healthcare.
Unanticipated 
financial cost of QOF.
Pharmaceutical 
industry resistance 
to NICE Influence on 
NHS decisions.
GPs seeing QOF 
and NICE as threats 
to their professional 
autonomy.
NHS reforms from 
2010 serve as a 
barrier to sustaining 
equitable, efficient 
components of NHS.
The economic 
recession of 2008-
Promising 
practices
• Implementation of the new GP contract in 2004, including QOF, raised the income of GPs, 
which made general practice more attractive as career and expanded the PC team as more 
nurses and other health professionals were employed by GPs to provide QOF and enhanced 
services through GP contract. Increased secondary prevention activity by GPs.
• NICE helped to standardise care across the NHS, ensure equitable access to new health 
technologies and value for money.
• Specialist training to become a GP has added to the acceptability and trust that patients 
need to accept the gatekeeping role of GPs and enhanced the status of general practice as a 
professional career choice.
• Purposeful initiatives to improve access and quality of PC in disadvantaged areas have 
provided examples of approaches to reversing the Inverse Care Law.
Source: Authors
Table 4. Factors that promote, sustain, or act as barriers to PC innovation (continued)
31
6. Discussion and 
conclusions
A t first sight, the British and the US healthcare arrangements are so fundamentally different that it is difficult to identify which features of the British 
system would be of interest and potentially transferable to 
the US context. This case study attempts to tease out useful 
lessons for further consideration by:
i. identifying the essential ‘ingredients’ that make 
the British NHS in general and the PC in particular 
function efficiently, effectively and equitably as a 
whole system and
ii. singling out some distinct/more self-contained policy 
initiatives that show potential for application to solve 
problems that other systems, including the USA, face.
Some aspects of the NHS vary slightly in the four countries 
of the UK, so for the purposes of simplicity, this case study 
describes the situation in England, though with some 
reference to initiatives in Scotland.
6.1 Essential ingredients of the NHS 
and PC
The English PC system must be understood within the 
context of a long-standing, publicly and politically popular 
universal healthcare system, the NHS, which was designed 
from the outset to be more equitable, efficient and effective 
than the patchwork of services it replaced. The building 
blocks of universal entitlement, equitable financing, services 
free at the point of use, comprehensive healthcare coverage, 
equality of geographic access, high standards of care for all, 
selection on the basis of need and the encouragement of a 
non-exploitative ethos underpin the policies and specific 
models that maintain and enhance NHS PC.
The NHS has a strong PC base in comparison to other 
OECD countries. As outlined in this paper, more than 
90% of healthcare interactions take place in PC, despite 
a PC budget of under 10% of the total NHS spending of 
approximately £105 billion/$175 billion annually. More than 
99% of the 52 million people living in England are registered 
with a general practitioner. Patient satisfaction with PC is 
very high and satisfaction with the NHS in general is high, 
although it has fallen since 2010. Section 3.5 details some 
impressive outcomes and impacts of the English NHS in 
comparison with other high-income countries, in terms of 
access, efficiency, and equity.
There are important components of the infrastructure for 
PC, described in this case study, that help make it strong: 
the common GP contract, support for common information 
systems and the use of those systems to establish professional 
norms that all help it function as a unified system. The 
information systems and patient records also supported 
the oversight of PC services by PCTs (responsibilities now 
partially taken over by the CCGs). As described in Section 
5, this monitoring and support, and the strategic role of 
the public health services within PCTs, were part of the 
mechanisms for managing change. The English experience 
of setting national targets for local services, however, 
including for PC, had both positive and negative effects and 
certainly generated resentment in some quarters.
The near universal registration of the population with a 
general practice is another asset, coupled with the fact that 
two-thirds of the population have a GP consultation every 
year, rising to 90% over five years. This provides levels 
of contact, coverage and continuity between PC and the 
general public achieved by few other public services.
Another important aspect is the role of GPs as gatekeepers 
to specialist care and beyond. Gatekeeping is seen as an 
essential, structural component of the system, reducing 
unnecessary and expensive access to specialists, and 
containing health problems within the community when 
they can be more appropriately treated. It also helps protect 
patients against over-treatment and excessive exposure 
– to radiation during diagnostic tests, for example. The 
gatekeeping role, however, could not function as intended 
without a high degree of trust by patients that GPs are 
making referral decisions in the their patients’ best interests, 
and not based on financial or other gain. The system for 
paying GPs has been such that GPs’ income is not dependent 
on how much or how little they refer (described in Section 
3.2). In addition, conflict of interest rules apply (at least until 
the latest reforms) which mean that GPs should not have a 
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financial interest in specialist services to which they may 
refer patients. That high degree of trust does in the main 
exist, not least because the system does not allow patients to 
be exploited for profit.
The case study identifies a somewhat intangible aspect that 
nonetheless makes the system work – the status of GPs 
and respect for their expertise. Public perceptions of GPs 
have been enhanced by general practice being treated as 
a specialism, requiring the depth of training approaching 
secondary care specialties. Also there have been continued 
attempts to raise the income levels of GPs to that of 
hospital consultants. These and other features of the system 
have raised the status of general practice and facilitated 
favourable public attitudes to PC and the trusted role of the 
gatekeeper in the system. How far the ethos of the NHS can 
be transplanted into a different culture is a matter for debate.
Relationships between PC providers and the public may 
have been enhanced in recent years through greater patient 
and public involvement (PPI) that is now operating at all 
levels of the NHS, described in Section 3.3. Voluntary 
sector support networks and organisations can play a key 
role in helping individuals navigate complex health systems, 
particularly during periods of change. Practice health 
champions have the potential to enhance patient access to 
decision making and may assist patients, particularly those 
from disadvantaged backgrounds, in understanding complex 
health issues and health systems. There is some indication 
of positive benefits from patient participation in decision 
making, on patients and the PC system and on reduction of 
costs, through ensuring that services are designed to meet 
the needs of local communities and increasing the quality 
and appropriateness of services. The extent of PPI is not 
uniform across PC, however, and can be tokenistic.
6.2 Lessons from promising PC 
initiatives 
A number of PC policy initiatives are outlined in the 
case study. These have been selected as they have been 
associated with improved health, or service or equity 
outcomes and hold some interest for application in the 
US. The first is the Quality and Outcomes Framework 
(QOF), introduced at a cost of more than £1billion/$1.7 
billion per annum, with the use of new money designed to 
address pay inequalities between GPs and hospital-based 
specialists to achieve additional benefits for the healthcare 
system. While other costs associated with its introduction 
(such as IT infrastructure) may be substantial, they bring 
additional benefits. The ability of practices to meet targets 
in the first year was underestimated and this increased 
costs over estimates considerably. Active monitoring in the 
QOF contributes to its impacts on quality and outcomes: 
through self-monitoring when practice staff are notified 
(automatically) by the QOF IT system where performance is 
falling short of targets; through monitoring of practices and 
feedback on their relative positioning vis à vis other practices 
by commissioning authorities and by public reporting, using 
reputation and accountability to spur practice improvements. 
The case study points to the potential for QOF to reduce 
inequalities by ensuring systematic management of chronic 
conditions, but also to increase inequalities by diverting 
attention from non-incentivised areas. Thresholds may act 
as a ‘quality ceiling’, preventing further improvements. 
This points to the need for careful selection and regular 
management over time of the indicators and related quality 
thresholds to avoid negative effects. Professional buy-in is 
also required to minimise gaming of the system.
The second is the introduction of NICE, which has 
standardised care in many areas across the NHS and helped 
to ensure equitable access to new health technologies. It 
has played a key role in balancing the costs and benefits 
of healthcare technologies (value for money). The strength 
of NICE is the imposition of national-level standards; the 
weakness is the inflexibility of those standards, which 
may undermine a doctor’s discretion to tailor treatment 
to individual patients. It provides a method and evidence 
potentially useful for other countries.
The third policy initiative is the promotion of the training 
and status of GPs as Expert Generalists. Specialist training 
has been characterised as fundamentally about managing 
uncertainty: learning how to make informed decisions 
about whether a condition is minor and self-limiting, 
minor and long-term, major but getting better and major 
but dangerous. It is also about encouraging practitioners 
to consider care as a whole, from health promotion and 
prevention to palliative care and about the psychological, 
the social and the biological aspects of people’s lives. Expert 
Generalists is the term the Royal College of GPs uses to 
characterise the specialist nature of the profession and, as 
mentioned above, it adds to the acceptability and trust that 
patients need to have in general practice that their GP has 
the necessary expertise to help them get the care they need.
Finally, there have been a series of experiments over the 
years to improve access to, and delivery of, PC services to 
disadvantaged groups and areas of the country, as outlined in 
Section 4.4. Some have proved relatively ineffectual – entry 
control and targeted incentives to increase supply of GPs 
in under-doctored areas could be seen as blunt instruments 
to bring about the desired shifts. Others, such as the GPs 
at the Deep End initiative in Scotland and the PC services 
adapted to serve the needs of homeless people in the North 
of England, provide inspiration on how to reverse the 
Inverse Care Law. Such initiatives are based on the premise 
that the best people to know how to improve PC services 
in disadvantaged areas are the people living and working 
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in these circumstances. These may be of particular interest 
to those working on similarly challenging circumstances in 
the USA.
It seems ironic that this case study, which set out to identify 
the strengths of the English PC system and what other 
countries might learn from it, is being written at a time when 
the NHS as a whole is under the greatest threat that it has 
faced in its 60-year history. How much longer the NHS as 
we know it can be maintained in the UK in the face of the 
fragmentation and commercialisation introduced in the 2012 
reforms are critical questions taxing the minds of the British 
public and professionals alike. Perhaps the most valuable 
lessons this case study can offer are for British politicians!
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Appendices
Appendix A1. Example of PC services available to registered patients
Table A1 outlines a real example of the PC services available to registered patients of a fairly typical group general practice 
(North West of England), 2014.
Table A1 – Example of PC services available to registered patients
Practice staff and patients:
• GP partners: 6 (4 wte)
• Salaried GPs: 4 (2 wte)
• Nursing team: 3 senior practice nurses; 1 staff nurse; 2 healthcare assistants
• Practice manager and administrative staff (all employed by the general practice).
• Other NHS staff working from health centre (but not employed by the general practice): district nurses; health 
visitors, community midwives
• Registered patients: 7,500    
Services Services normally provided by
Medical consultations: personal, telephone and, 
occasionally home visits, prescribing, minor surgery (from 
some specifically trained GPs only).
GPs.
Practice nurse consultations: all childhood immunisations 
(delivery of national system); cervical cancer screening 
(delivery of national system); flu/pneumonia vaccination 
(delivery of national scheme for all patients classed as 
at higher risk); minor nursing procedures; health checks 
(national scheme).
Nursing team.
Phlebotomy: diagnostic and monitoring blood tests. Nursing team or other NHS staff (phlebotomists).
District nursing services: for treatment in the patient’s 
home, arranged through the GP.
Other NHS staff (district nurses).
Chronic disease clinics: asthma and COPD, patients invited 
to attend at least annually.
Nursing team, with GP and other NHS staff 
involvement as appropriate.
Diabetes clinic: patients invited to attend every 6 months 
routinely.
Nursing team, with GP and other NHS staff 
involvement as appropriate.
Cardiovascular clinic: patients who have had a heart attack 
of stroke or angina invited to attend at least annually.
Nursing team, with GP and other NHS staff 
involvement as appropriate.
Family planning clinic: twice weekly Nursing team, GPs.
Maternity: shared care plan between GPs and hospital 
midwives. Community midwives hold clinics in the health 
centre weekly.
Other NHS staff (midwives).
Health and welfare of babies and young children: health 
visitors offer advice to every new mother and their child in the 
practice and run the Child Development Clinics at the health 
centre.
Other NHS staff (health visitors).
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Services Services normally provided by
Dietetics and smoking cessation: Referral by GP to special 
services provided at the health centre.
Other NHS staff (e.g. dieticians) with nursing team 
involvement as appropriate.
Counselling: Referral by GP to trained (mental health) 
counsellor at the health centre.
Other NHS staff (mental health counsellors).
Provision for carers: A Carer’s Protocol states how the 
practice provides support and care for those people who are 
carers for others.
Led by GP with other practice, NHS and social work 
professionals (e.g. nurses, social workers and mental 
health councillors) involvement as appropriate.
Patient Reference Panel: consists of patients from a variety 
of ages and background, to enable involvement of patients 
with the GPs and practice staff and to enable linkages with 
other local patient groups in the locality.
Practice manager led. GPs, nursing and other NHS 
staff involved as appropriate)
Source: KI: Practice manager.
Appendix A2. The Quality Outcomes Framework
The current indicator groups in the Quality and Outcomes Framework, organised within their domains, are listed below:
Source: Health and Social Care Information Centre, 2013.
Table A1 – Example of PC services available to registered patients (continued)
Clinical domain
• Coronary heart disease
• Cardiovascular disease
• Chronic Obstructive Pulmonary Disease
• Diabetes
• Hypothyroidism
• Mental health
• Chronic kidney disease
• Asthma
• Atrial fibrillation
• Osteoporosis: secondary prevention of fragility 
fractures
• Heart Failure
• Stroke and Transient Ischemic Attack
• Hypertension
• Cancer
• Palliative care
• Dementia
• Chronic kidney disease
• Learning disabilities
• Smoking
• Obesity
Organisational domain
• Records and information
• Education and training
• Medicines management
• Information for patients
• Practice management
• Quality and productivity
Patient experience domain
• Patient experience
Additional services domain
• Cervical screening
• Maternity services
• Child health surveillance
• Contraception services
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As an example, the QOF indicators, points and achievement thresholds for Diabetes Mellitus are shown in Table A2
Table A2 QOF Diabetes mellitus (DM) indicators
Indicator Points Achievement 
thresholds
Records
DM017. The contractor establishes and maintains a register of all patients aged 
17+ yrs with diabetes mellitus, with the type of diabetes if diagnosis has been 
confirmed
0-6
Ongoing management
DM002. % patients with diabetes, on the register, in whom the last blood 
pressure reading (measured in the preceding 12 months) is 150/90 mmHg or less
0-8 53-93%
DM003. % patients with diabetes, on the register, in whom the last blood 
pressure reading (measured in the preceding 12 months) is 140/80 mmHg or less
0-10 38-78%
DM004. % patients with diabetes, on the register, whose last measured total 
cholesterol (measured within the preceding 12 months) is 5 mmol/l or less
0-6 40-75%
DM006. % patients with diabetes, on the register, with a diagnosis of 
nephropathy (clinical proteinuria) or micro-albuminuria currently treated with an 
ACE-I (or ARBs)
0-3 57-97%
DM007. % patients with diabetes, on the register, in whom the last IFCC-HbA1c 
is 59 mmol/mol or less in the preceding 12 months NICE 2010 menu
0-17 35-75%
DM008. % patients with diabetes, on the register, in whom the last IFCC-HbA1c 
is 64 mmol/mol or less in the preceding 12 months
0-8 43-83%
DM009. % patients with diabetes, on the register, in whom the last IFCC-HbA1c 
is 75 mmol/mol or less in the preceding 12 months
0-10 52-92%
DM012. % patients with diabetes, on the register, with record of a foot 
examination and risk classification: 1) low risk (normal sensation, palpable 
pulses), 2) increased risk (neuropathy or absent pulses), 3) high risk (neuropathy 
or absent pulses plus deformity or skin changes in previous ulcer) or 4) ulcerated 
foot in past 12 mths
0-4 50-90%
DM014. % patients newly diagnosed with diabetes, on the register, in the 
preceding 1 April to 31 March who have a record of being referred to a structured 
education programme within 9 mths after entry on to the diabetes register
0-11 40-90%
DM018. % patients with diabetes, on the register, who have had influenza 
immunisation in the preceding 1 August to 31 March
0-3 99-95%
Source: BMA, 2014.
Appendix A3. A patient participation 
group/patient reference panel
An example practice identified for this study already had a 
face-to-face patient reference group (PRG) before additional 
funding from the Enhanced Services element of the (GMS 
or PMS) medical services contract was available. They 
currently use three approaches to participation and feedback 
from patients.
i. Active promotion of a face-to-face patient participation 
group through adverts in the practice waiting room 
and using Facebook and Twitter, but uptake is low and 
membership is limited to about 10 core patients:… 
that’s not really representative of our practice at all 
(KI: practice manager). Meetings are organised and 
delivered by one member of staff. Other members 
of the practice team and CCG staff participate when 
meetings are likely to inform their work or members 
request input on specific matters.
ii. Conducting virtual surveys (an Enhanced Service) to 
reach a wider group of patients, and to allow anonymous 
feedback. … that’s much more representative and it’s 
anonymous as well, so you do get some real frank 
feedback that you probably wouldn’t get in a face-to-
face meeting, which is useful (KI: practice manager). 
Participants are invited to participate in online surveys 
through text messages that are sent to all patients who 
have mobile phones. The face-to-face group help to 
design the online surveys. The survey tool captures 
some information on representativeness in terms of 
the age, sex and ethnicity of participants.
40
iii. They also capture the views of one of their three key 
population groups through one of their specialist 
nurses who “links into” a (group specific) local 
charities through regular “peer group” meetings. The 
potential benefits to the patients and to the practice 
include: … it saves on time doesn’t it, because if we 
set up a service that isn’t used, or a patient thinks it’s 
a complete waste of time, then that’s a method that 
we don’t need to do, if we get it right first-time that’s 
brilliant really (KI: practice manager).
Changes to funding arrangements later in 2014 may have an 
impact on the money that is available to practices for PRG 
enhanced services (by diverting resources to a new Friends 
and Family Test/questionnaire). However, this practice 
seems determined to continue using their current approach: 
I’m not sure that’s going to stop us… we’ve had the face-to-
face PRG group for about 8 years or more and that was way 
before the PRG [funding] came along. So I don’t think… 
the reduction is going to have an impact on that and we 
actually find the texts and asking patients to fill in the survey 
monkey really useful. We get loads of really rich feedback 
there so that’s something that… we don’t do because we get 
funding for it, we do that because we want to be on the mark 
in regards to what services patients will access and how we 
design them. We’re only going to be a successful practice 
if we design services that our patients will use. So that’s 
for us as practice to benefit from to be honest (KI: practice 
manager).
Appendix A4. An example of practice 
health champions
This is an anonymised example of a non-state organisation, 
the ‘Health Champion Group’. It was established in 2008 
with the aim of recruiting, engaging, training and supporting 
local people as health champions to work with others in their 
communities to improve health and wellbeing. The group 
received around £7 million ($12 million) of funding from the 
Big Lottery Health and Wellbeing fund to deliver flagship 
projects in the north of England over five years. They 
initially worked with a University to develop an evidence 
based community health champion model and an evidence 
summary of the value of community health champions. 
By the end of the project in 2013 they had recruited over 
17,000 champions to deliver health initiatives to over 
100,000 people. They originally started by working in 3 
general practices within 3 former PCTs in a northern city 
to establish prototypes. The Group now work with 13 CCGs 
with practice health champions embedded in, delivered and 
paid for by general practices (KI: Health Champion Group). 
In 2013 they received a second stage of Big Lottery Health 
and Wellbeing funding money to develop their champion 
model in new 6 new locations and to engage and train 
local people to become Practice Health Champions, Youth 
Health Champions and Pregnancy and Early Parenthood 
Champions.
The Group worked with linguistic analysts to produce simple 
effective invitations for local people to participate and work 
with general practice staff as peers or equals to improve local 
health and wellbeing. They sent personalised text and email 
messages seeking participation and put up simple notices 
in practices that stood out from corporate/glossy posters 
and asked people to either talk to named receptionists or 
call named individuals (KI: Health Champion Group). They 
also went to where people are [including] school gates, 
community centres, cafes, and within practices and got 
practice staff such as receptionists to invite people directly. 
The initial/induction meetings were used to develop build 
relationships/teams, motivate and develop capacity – find 
out what people are interested in, to get to know people and 
simple work on ‘what is health, what are the determinants 
of health and what are inequalities in health? (KI: Health 
Champion Group). This included information on their local 
areas in comparison to other areas to draw attention to local 
level inequalities/issues. They report participation from 
“a truly diverse group of people” including a broad and 
locally representative range of socioeconomic, ethnic and 
age groups. Key ways of getting a broad group of people 
involved include:
• Inviting … people to work as peers or equals, paying 
particular attention to language, which is really 
important.
• They work with fun and excitement and lots of good 
cake… not [formal] agendas, chairs, note takers… 
and that’s what keeps people coming back and keeps 
people connected.
• They apply the things that work in their personal lives; 
they don’t leave their humanity in the car when they 
come to work (KI: Health Champion Group).
Health Champion Group then arrange a whole practice 
meeting with community health champions and practice 
staff (GPs, nurses, receptionists, practice managers) with 
the aims of:
• Establishing a group approach: how we are going to be 
together and come up with a contract about how they 
will work together. They resist talking about what they 
will do at first.
• Establishing what’s important to us (why are we in the 
room today, what brought us to this place, what really 
matters to us).
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• Starting to identify overlaps/commonalities between 
practice staff and the community health champions, 
and then work out what they are going to do together 
(KI: Health Champion Group).
Their work varies across practices/localities, with practice 
champions and practice staff co-producing priorities 
for their local practice and developing different ways of 
working and providing new solutions together. They focus 
on what’s needed and what people are passionate about in 
the community – people need to be able to choose – they 
have no energy when they are told what to do and they are 
chasing other peoples’ priorities (KI: Health Champion 
Group).
Health Champion Group support the champions for at least 
a year to work with the practice: what works well is about 
a one hour meeting every fortnight with the champions, 
the practice manager and the [Health Champion Group] 
project leads – and that’s where the work happens. They 
need to have the practice involved so that the champions 
aren’t developing something that the practice doesn’t want. 
In the bigger practices they may get 2 or 3 staff involved in 
these meetings (KI: Health Champion Group). During the 
support meetings they model how they work with citizens 
and manage other volunteers. The … things that they do 
together are remarkable, in terms of the outcomes, they’ve 
seen service improvements, quality improvements, service 
redesign and they are really interested in commissioning 
improvements (KI: Health Champion Group).
The key informant gave an example of: Champions in every 
one of a CCG’s practices – so champions in 44 practices, so 
with a minimum of only 20 in each practice that’s 880 people 
– so you’ve got a commissioning voice, an authorising 
environment, a place to legitimatise commissioning 
decisions. The people who are there [the practice health 
champions] are not lobbyists – there because they just want 
better services for people with diabetes or because they are 
parents of children with special needs – they are a really, 
really diverse range of ordinary citizens, and there’s lots of 
them. So it’s really different proposition what’s been used in 
the past (KI: Health Champion Group).
Fischer (2013 no page number) identifies examples of 
their work and its impacts as: a social group for young 
mothers, setting up a support group for people with chronic 
obstructive pulmonary disease, and speaking to patients 
in local communities and in the surgery waiting rooms 
to improve the uptake of immunisations and screening. 
They are also beginning to explain to other patients how 
to make best use of the practice, including how to use the 
Appointment Guide, thereby improving access for those 
whose first language is not English. By providing support 
to patients before the consultation, and a new range 
of options for patients after the consultation, Practice 
Health Champions are beginning to be treated as peers 
by the practice staff and have shown themselves to be a 
key contributor to NHS improvement that grows outward 
from the [GP] consultation and its context. Their local 
understanding may help to overcome problems relating to 
health literacy and representative engagement in deprived 
communities. They bring culturally specific, local networks, 
knowledge and experience (that health professionals may 
lack) together with the healthcare knowledge and resources 
of the practice (that the champions may lack) and together 
they can produce something that they could not do before… 
it’s about mobilising the resources in the community and 
within the practice (KI: Health Champion Group).
Appendix A5: Type 2 Diabetes in UK
Type 2 diabetes mellitus is a common form of diabetes 
that 90% of all diabetics in the UK have (Diabetes UK, 
2010). Certain individuals are believed to have a genetic 
susceptibility to Type 2 diabetes, although it’s preventable 
in most cases. Poor diet, lack of exercise and increasing age 
reduce the pancreases efficiency in producing insulin and 
the body’s fat, liver and muscle cells efficiency in utilising 
it to produce energy (Medline Plus, 2013). It is generally 
treated through diet, exercise and tablets (for more serious 
cases) designed to increase the body’s efficiency in utilising 
insulin. In the UK, there is a greater prevalence of diabetes 
amongst males in all age groups ≥35 years of age. Prevalence 
rates increase with age from less than 1% in 16 to 24 year 
old up to 15.7% for males and 10.4% for females for the 
age group 65 to 74, after which they decrease for males as 
the result of higher mortality rates relative to the general 
population.
There are a range of serious complications and co-morbidities 
associated with diabetes that include heart disease, eye 
disease, kidney disease, nerve damage and depression. 
People with diabetes are twice as likely to be admitted to 
hospital compared to the general UK population (Diabetes 
UK, 2009). Diabetes is associated with higher mortality 
rates. For example, in a systematic review Nwaneri et al 
(2013) found 33 studies that reported increased mortality 
risks for people with Type 2 diabetes. In their meta-analysis, 
type 2 diabetes was associated with an 85% increased risk 
of mortality in comparison with non-diabetics (all-cause 
mortality RR = 1.85, 95% CI 1.79-1.92). 11.6% of deaths of 20 
to 79 year olds in England are related to diabetes (Diabetes 
UK, 2010). Life expectancies of people with diabetes are 
reduced on average by over 15 years for Type 1 and between 
5 and 7 years for Type 2 diabetics (Roberts, 2006).
The costs associated with diabetes are considerable. For the 
financial year 2010/2011 Hex et al (2012) estimated the direct 
costs to the health service in the UK (for diagnosis, treatment/
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management, lifestyle interventions, and complications) of 
Type 1 and Type 2 diabetes at £9.8/$16.68 billion (£1/$1.7 
billion for Type 1 diabetes and £8.8/$14.98 billion for Type 
2 diabetes and this represented approximately 10% of total 
health resource expenditure. They predicted this could rise 
to approximately 17% of health resource expenditure in 
2035/2036. Diabetes related complications increase NHS 
costs more than fivefold (Diabetes UK, 2009).
There is strong evidence of associations between 
socioeconomic status and type 2 diabetes. For example, The 
Whitehall II prospective cohort study of (n=7237) adults 
without diabetes at baseline found, over a follow-up of 14.2 
years, that participants in the lowest occupational category 
had an 86% increased risk of developing diabetes compared 
to those in the highest occupational category (OR = 1.86, 
95% CI = 1.48 to 2.32). In a systematic review, Agardh et 
al (2011) found relationships between multiple measures of 
socioeconomic status and incidence of Type 2 diabetes. In a 
comparison with high levels (reference group RR = 1.0), they 
found that low educational level [relative risk (RR) = 1.41, 
95% CI: 1.28-1.51, P<0.001], low income level (RR= 1.40, 
95% CI: 1.04-1.88, P=0.002) and low occupational status 
(RR =1.31, 95% CI: 1.09-1.57, P<0.02) were associated with 
increased risk of Type 2 diabetes.
Standards of care for diabetes were originally established by 
the diabetes National Service Framework (NSF) in 2001 with 
the aims of developing a patient centred service, improving 
health outcomes for people with diabetes, raising the quality 
of services and reducing inequalities (NHS Choices, 2011). 
In 2011 NICE produced new Quality Standards for Diabetes 
to support the NSF (See: http://guidance.nice.org.uk/QS6). 
They contain quality standards for key areas of care such 
as: structured education; nutritional and physical activity 
advice; care planning; glycaemic control; medication and 
insulin therapy. The quality standards are publicly available 
and have an intended audience of commissioners, service 
providers, healthcare professionals and people with diabetes/
carers; this allows people with diabetes, carers and other 
interested bodies to measure the care an individual receives 
against the standards. NICE also provides a pathway for 
diabetes. The pathway, part of which is illustrated in Figure 
A1 is supported by publicly available, evidenced based 
clinical guidance on prevention (of type 2) and management 
of diabetes and related complications (such as http://tinyurl.
com/kx24jnw). NICE guidance recommends that all people 
with Type 1 and 2 diabetes are screened for retinopathy on 
diagnosis and annually thereafter. The NSF for diabetes 
introduced a national screening programme based on digital 
retinal photography. Local opticians are private businesses 
who also receive funding from the NHS for screening and 
for free sight tests to certain groups (see: http://tinyurl.com/
kn8g4xb).
Figure A1. Illustration of NICE Pathway for diabetes
Source: Author adapted from NICE (2011)
Diabetes
Preventing type 2
pathway
Managing type 1 Managing type 2
Foot care for people 
with diabetes
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Appendix A6. Ranking of health system performance in high income 
countries
Table A6 Overall ranking of health system performance in 11 high-income countries
AUS CAN FRA GER NETH NZ NOR SWE SWIZ UK USA 
OVERALL  RANKING (2013) 4 10 9 5 5 7 7 3 2 1 11 
Quality Care  2 9 8 7 5 4 11 10 3 1 5 
Eective Care  4 7 9 6 5 2 11 10 8 1 3 
Safe Care  3 10 2 6 7 9 11 5 4 1 7 
Coordinated Care  4 8 9 10 5 2 7 11 3 1 6 
Patient-Centered Care 
 
5 8 10 7 3 6 11 9 2 1 4 
Access  8 9 11 2 4 7 6 4 2 1 9 
Cost-Related Problem 9 5 10 4 8 6 3 1 7 1 11 
Timeliness of Care 6 11 10 4 2 7 8 9 1 3 5 
 4 10 8 9 7 3 4 2 6 1 11 
Equity  5 9 7 4 8 10 6 1 2 2 11 
Healthy Lives
 
4 8 1 7 5 9 6 2 3 10 11 
Health Expenditures/
Capita, 2011** $3,800 $4,522 $4,1 18 $4,495 $5,099 $3,182 $5,669 $3,925 $5,643 $3,405 $8,508 
COUNTRY RANKINGS
Top 2* 
Middle 
Bottom 2* 
Efficiency
Notes: * Includes ties. ** Expenditures shown in $US PPP (purchasing power parity); Australian $ data are from 2010.  
Source: Reproduced with permission from the Commonwealth Fund from Exhibit ES-1. OVERALL RANKING.in Davis et al, (2014) 
Mirror, Mirror On The Wall. How the Performance of the U.S. Health Care System Compares Internationally © The Commonwealth 
Fund, 2014.
Appendix A7 Delivery of PC in the most deprived areas
A7.1 GPs at the Deep End
During their first 15 meetings (2009 to 2011) GPs at the 
Deep End prepared the following reports:
1.  General practitioners at the deep end
2. Coping with needs, demands and resources
3. The GP role in working with vulnerable families
4. Experience and views of Keep Well and ASSIGN
5. Single-handed general practice
6. Patient encounters in very deprived areas: what can be 
achieved?
7. General practitioner training in very deprived areas
8. Social prescribing
9. Learning journeys
10. Care of elderly patients
11. Alcohol problems in adults under 40
12. Working together for vulnerable children and families
13. The Access Toolkit: views of Deep End GPs
14. Reviewing progress in 2010 and plans for 2011
15. Palliative care in the deep end
The issues faced by the Deep End practices in Scotland and 
their proposals for solutions are outlined in Section 4.4, 
noting that the proposals are intended to be applied together 
as a demonstration of integrated care for patients with 
multimorbidity, an antidote to health service fragmentation 
and a model for NHS Scotland in the future (GPs at the Deep 
End 2013:3).
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A7.2 Further information on general practice 
services to homeless people
While the practice’s work with homeless people, one of 
three main population groups served by the practice, is 
not economically viable in terms of the direct funding it 
brings into the practice, they describe other benefits and the 
importance of the work to the practice: … now we’re funded 
about £90,000 a year, obviously… we’re able to invest in our 
team and provide lots more of these services, but it’s never 
really to be honest been about the money it’s been about the 
ethos of the practice and that’s definitely just comes from a 
special interest… (KI: Practice Manager).
… from a financial point of view it’s not economically 
viable to do that, but from a practice ethos point 
of view the practice has always been interested in 
this vulnerable group of patients… and we think it 
probably helps us to recruit really excellent clinical 
staff because our populations [are] so diverse so you 
don’t know what’s going to walk through the door, and 
that’s exciting to the clinic team… and these patients 
deserve the same as you or I deserve… so that’s why 
were interested in it. (KI: Practice Manager).
The waiting room mentor’s work benefits both the patients 
and the practice: 
…he has numerous roles, one… that is really valuable 
is the waiting room manager. So on a Thursday 
afternoon… there can be a fight in the waiting room… 
there can be all kinds going on and he’s just very 
good at calming situations down, splitting situations 
up and actively managing what’s going on really 
and… in a non-police like way. So… in the past we’ve 
had to call security or we’ve had to call the police 
because we’re not set up to manage that kind of 
chaos and… he manages that in a supportive way… 
after he’s spoken to them they know they are not 
allowed to fight in the waiting room. …he manages 
that situation often just splits groups of patients up 
to be honest, generally just fighting with each other 
he will split them up and then link in with them at a 
different time and find out what’s going on, if there’s 
any support [required] (KI: Practice Manager).
The specialist nurses, employed and specialising in hepatitis 
C and in alcohol abuse have made care, normally only 
available in a hospital setting, more accessible contributing 
to improved diagnosis, treatment and prevention of these 
conditions: …one of the services that we are really proud 
of is, there’s two… we employ a hepatitis C nurse within the 
practice who is now able to treat hep C patients in primary 
care. So we were the first practice… to do that and we have 
people presenting at conferences, won awards... We’re 
really proud of that, the reason that we do it is because 
patients won’t go into hospital so we thought we need to 
bring the service to them… because this is a preventable 
disease and in primary [care], we’ve treated about 70 
patients now over the 5 years we would never have engaged 
in hospital services. The other one is the alcohol outreach 
nurse so in [their area] we’ve got [a local alcohol] treatment 
service. But you have to go to the clinic to get access to the 
service and these patients don’t use that place [because]: 
it’s the bus fare; they don’t have the mobile phone to make 
an appointment - they don’t engage like that (KI: Practice 
Manager).
Specialist training is important part of the investment and 
has been done using innovative approaches: We invest a lot 
of time and effort in our team in training for this group of 
patients as well, so… once a year we’ll have… hot topics 
related to this, the last one we had at the [name of local 
venue] non-alcohol bar place we held it there and had like 
public health come in and we did alcohol training we had 
different services like [a substance missus recovery service] 
and different… [providers] come in and showcase their 
service to us and so our team aware of what services are 
out there that we can link these patients into (KI: Practice 
Manager).
In the past we’ve had… a drama group drama training 
provider [who] provided training on customer care training 
really on how to manage these different groups of patients 
and ‘how they are feeling and what did you think about that, 
how do you think so and so felt, how do you think that could 
have been done differently?’ So we invest heavily in that… 
(KI: Practice Manager).
In terms of costs and benefits to the wider NHS the 
homeless patients represented just 2.7% of the practice’s 
registered patients, but were accounting for 21% of 
emergency admissions and 34% of Ambulatory Care 
Sensitive admissions, with large costs to NHS primary and 
secondary care. 
[ACS] Ambulatory Care Sensitive admissions are 
the measure that primary care have so its things like 
angina, asthma, cellulitis, COPD, CHD, convulsions, 
epilepsy, diabetes, ENT, flu and pneumonia and 
they’re conditions that you should manage effectively 
in primary care, so if your patients are admitted with 
one of those ACS conditions it’s a bit like a black 
mark against you. They think patients should be 
managed effectively before they get… admitted with 
those things but that’s one of the measures that the 
CCG have for practices, and in that same period 
with that same mix of patients 34% of them were 
homeless, so that’s the kind of resource they use… 
(KI: Practice Manager).
When the full costs and benefits to the NHS are considered, 
the provision of services to homeless people in PC may 
represent excellent value for money. (KI: Practice Manager).


